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Abstract
Tumey, Jonathan Michael, M.S. Department of Chemistry, Wright State University, 2017.
Synthesis and Reactivity of Sydnone Derived 1,3,4-Oxadiazol-2(3H)-ones.

5-(Bromomethyl)- and 5-(trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-ones
were synthesized from bromocarbonyl hydrazine intermediate salts and acid halides to
provide further evidence for our proposed mechanism for the formation of oxadiazolone
ring systems from sydnones. 5-(Bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one was
a compound of interest due to its SN2 possibilities and three potential sites of
diversification. The procedure to synthesize 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol2(3H)-one was developed originally by Madaram in the Turnbull lab, but was further
optimized in the present work by altering the time, temperature and stoichiometric
equivalents of the acid halide to provide high purity and excellent yields of the product.
While this compound of interest had been isolated and characterized previously it had yet
to be probed for chemical reactivity and, accordingly, it was subjected to a variety of
nucleophilic and electrophilic reagents. For hard nucleophiles, an attack at the hard,
carbamate carbonyl group was observed, resulting in undesirable ring-opening of the
oxadiazolinone ring system. Accordingly, hard, but bulky, substrates were utilized in
order to impede an attack at the carbamate carbonyl group and favor one at the alkyl
halide functionality but, unfortunately, this resulted in no reaction. Soft substrates
preferred the SN2 possibility at the methylene group attached to the C5-position and, in a
few cases, viz. with sodium azide and ammonium thiocyanate, successful displacement of
the halogen was observed. Electrophilic aromatic substitution (EAS) of 5-methyl-3iii

phenyl-1,3,4-oxadiazol-2(3H)-one was explored by Gerritsen, Klaasen and Conde in the
Turnbull lab, with the result that nitration, bromination and iodination were shown to
occur at the para position of the phenyl ring attached to the oxadiazolinone. In the
present work, nitration was extended to the 5-bromomethyl oxadiazolinone and its
chloromethyl congener, however, under the previously employed conditions, inseparable
mixtures were obtained. Accordingly, the amount of nitrating agent was increased to
provide the corresponding dinitro compounds where substitution was both para and ortho
to the oxadiazolinone ring. All oxadiazolinones synthesized were characterized by
GC/MS, 1H and 13C NMR and IR spectroscopies.
The second focus of this work considered the optimization of a route to chlorinate
3-arylsydnones utilizing ICl in DCM. Imad Nashashibi of the Turnbull lab, had
previously attempted this reaction and observed the formation of two products, viz. the 4chloro- and 4-iodo-3-arylsydnones. In the present work, the time and the molar
equivalents of ICl were manipulated, providing satisfactory yields and purity of the 4chloro congener alone. A series of 4-chloro-3-arylsydnones were prepared and
characterized by melting point analyses along with 1H NMR and 13C NMR spectra. With
the 4-chloro sydnones in hand, their conversion to the corresponding oxadiazolinones
was explored. Previously, 3-arylsydnones had been converted to oxadiazolinones using
bromine in acetic anhydride as both solvent and reagent, however, in the present work, it
was elected to react the 4-chloro-3-arylsydnones with acetic anhydride in acetic acid as
solvent. The corresponding 5-methyl-3-aryl-1,3,4-oxadiazol-2(3H)-ones were obtained
by this novel process in high yields and purity and were characterized by their melting
points and their 1H NMR and 13C NMR spectra.
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Sydnone Background
Sydnones were first discovered by Earl and Mackney in Sydney, Australia in 1935 from a
study of the action of acetic anhydride on N-nitrosoglycines and derivatives thereof.1 The model
N-nitroso compound 1 was synthesized from N-phenylglycine and the former was converted to a
novel, crystalline compound of unknown structure by treatment with acetic anhydride at room
temperature. Earl and Mackney proposed that this species had a unique bicyclic structure 2
composed of fused 3 and 4 membered rings.1
Scheme 1: Synthesis involving N-nitroso-N-phenylglycine and acetic anhydride to form a
sydnone1

The sydnone synthesized as in Scheme 1 was subjected to aqueous acid and base
(separately) in the presence of heat. Decomposition was observed in both cases, with
fragmentation into phenylhydrazine, formic acid and carbon dioxide occurring quantitatively in
acid and N-nitroso-N-phenylglycine being regenerated under basic conditions.1 While
decomposition had occurred in both cases, the relatively vigorous conditions necessary indicated
that the strained bicyclic representation 2 was unlikely. Thus, in 1949, Baker, Ollis and Poole2
suggested that a monocyclic, dipolar representation, as shown in Scheme 2, was more reasonable
on the basis of lessened ring strain, the absence of optical activity in sydnones and the fact that
the phenyl ring in structure 2 should be activated and susceptible to electrophilic species (it is

1

not). Additionally, Baker Ollis and Poole recognized that substitution of bromine on the sydnone
ring occurred at the C-4 position, something hard to explain with structure 2.2
Further, Kenner and Mackay 3 showed in a specific case that optical activity was not
present in the sydnone product, thus negating Earl and Mackney’s proposed structure 2. With
this evidence in hand, Baker et al. modified the sydnone structure to a monocyclic, dipolar, 5membered ring hybrid of various resonance forms 3a-h (see Scheme 2).
Scheme 2: Major resonance contributors and IUPAC numbering of N-substituted sydnones.2

Sydnones were the first examples of this type of structure and, accordingly, a new term,
mesoionic (mesomeric / ionic), was coined2 to describe this situation. For a molecule to be
mesoionic, Baker et al. stated that certain rules must be followed, viz. the species must be a 5 or
6 membered, planar, heterocyclic ring with both a + and – charge. The ring should have
considerable resonance energy and an exocyclic atom or group capable of bearing a partial
negative charge.2
In general, most researchers draw the sydnone ring as resonance form 3a in Scheme 2,
since the latter emphasizes the aromatic nature of the compound.
2

Properties of Sydnones
Since sydnones are pseudo-aromatic compounds, this makes the sydnone ring reactive
toward electrophilic substrates.3 Accordingly, as mentioned previously, it is common to represent
the ring as resonance form 3a in Scheme 2. However, spectrometric techniques such as IR, 1H
NMR and 13C NMR may or may not concur with this supposition. For example, IR and 13C
NMR spectra both indicate the presence of a “pseudo-carbonyl” which appears often as a sharp,
well-resolved signal.
Thus, sydnones can be characterized by a C=O stretch (~1744 cm-1) at the C-5 position
and, if a hydrogen is present, the C-H absorption at the C-4 position (~3150 cm-1).1 Further
characterization involves 1H NMR and 13C NMR spectroscopy. In the 1H NMR spectrum of a
sydnone, there is a unique signal at ~6.8-7.0 ppm for the hydrogen attached to C-4, if present.
The 13C NMR spectrum contains two signals corresponding to the C-4 and C-5 positions on the
sydnone ring at ~95 ppm and ~165 ppm, respectively. The relatively unusual positions of these
peaks can be very helpful in determining the presence or otherwise of the sydnone moiety.
Synthesis of Sydnones
Sydnones are readily prepared from aniline derivatives or N-substituted glycines.1 If the
requisite glycine is unavailable commercially the appropriate aniline derivative can be
transformed into the corresponding glycine (e.g., 4), usually by reaction with ethyl bromoacetate
followed by hydrolysis. The prepared or purchased glycines can then be converted into Nsubstituted N-nitrosoglycines and undergo cyclization with acetic anhydride (or other anhydride)
to form the sydnone ring, as shown in Scheme 3.1

3

Scheme 3: Synthesis of sydnones from anilines via glycines1

Reactions of Sydnones
Notable reactions of sydnones include 1,3-dipolar cycloadditions with alkenes and
alkynes wherein reaction occurs across the sydnone N-2 and C-4 positions, resulting in extrusion
of carbon dioxide and the formation of pyrazoles.5 Alternatively, heating sydnones in the
presence of acid has been reported as a synthetic route to monosubstituted hydrazine salts.6
If the sydnone ring is unsubstituted at the C-4 position (H present) it is prone to
electrophilic aromatic substitution (EAS), as shown in Scheme 4, and to metallation4.
Scheme 4: EAS opportunities for sydnones unsubstituted at the C-4 position

As mentioned above EAS is the most studied area of sydnone reactions and, accordingly,
will be discussed in more detail. Previously reported EAS reactions include acylation7,
halogenation8, nitration9 and sulfonation10. The most studied type of EAS reaction in sydnone
chemistry is halogenation at the C-4 position and the most studied halogenation reactions of
sydnones involve bromination11 and chlorination12. Bromination was first accomplished in 1946
by Kenner and Mackay using bromine in acetic acid (Scheme 5) and, subsequently, other
reagents such as NBS14 and KBrO3 / HBr13 were used successfully.
4

Scheme 5: First reported bromination of 3-phenylsydnone3

Chlorination of sydnones has also been accomplished by a variety of methods including,
Cl213, NCS/DMF14, KClO3/HCl15 and PhICl216. In contrast, until recently, iodination of sydnones
had proven to be much more difficult, however, two efficient methods are now available, viz.
ICl/AcOH17 and NIS/AcOH.18

1,3,4-Oxadiazol-2(3H)-one Background
IUPAC Numbering of 1,3,4-Oxadiazol-2(3H)-ones cf. 6
The oxadiazolinone ring system is numbered first from the oxygen and, in principle, then
in the direction that would give the lower numbers for the remaining heteroatoms. Since the N
atoms will be numbered 3 and 4, whichever direction is followed, then the usual rules prioritize
functional groups next. Again, there is a functional group at 2 in either direction but the priority
goes to the C=O group. The “-2(3H)-one” identifier indicates that the C=O is attached to the N3
nitrogen through a bond to the C2 position. An example of the numbering for the ring system of
interest to this present work is provided in Figure 1.

5

Figure 1. IUPAC numbering for 1,3,4-oxadiazol-2(3H)-ones 6

Synthesis of 1,3,4-Oxadiazol-2(3H)-ones
The first reported synthesis of a 1,3,4-oxadiazol-2(3H)-one was conducted by Diels and
Okada in 1912.19 These workers had been attempting to synthesize hydrazides from 7 under
basic conditions and obtained an unidentified heterocycle instead (see Scheme 6). A year later,
the latter was identified as structure 8 by Stolle et al.20
Scheme 6: First documented synthesis of a 1,3,4-oxadiazol-2(3H)-one

The next notable synthesis was discovered in 1949 by Dornow and Bruncken when they reacted
hydrazides with phosgene gas in a mild solution of HCl and successfully isolated 1,3,4oxadiazol-2(3H)-ones (Scheme 7).21
Scheme 7: Synthesis of 1,3,4-oxadiazol-2(3H)-ones from substituted hydrazides and phosgene21

6

The synthesis of 1,3,4-oxadiazol-2(3H)-ones was revisited by Stempel et al. as a route to
hydrazides without the use of the reagent hydrazine.22 Apparently, after WWII there was a
threatened shortage of hydrazine and, accordingly, it became of interest to develop alternative
routes to hydrazides. This group exploited both the reaction of substituted ureas with chlorine
gas, followed by quenching with aqueous base and stirring in AcOH at room temperature, and
hydrazides with phosgene gas as routes to 5-pyridinyl-1,3,4-oxadiazol-2(3H)-ones. The latter
were isolated via these routes in relatively low yields, however, the purity was sensitive to the
strength and concentration of the mineral acid used as solvent.22 The compounds obtained by
Stempel et al. via the method shown in Scheme 8 were then compared to the 1,3,4-oxadiazol2(3H)-ones obtained by reacting isonicotinyl hydrazides with phosgene gas to ensure that the
products obtained were identical.22
Scheme 8: Synthesis of chloroureides using chlorine gas followed by subsequent transformation
to 1,3,4-oxadiazol-2(3H)-ones22

Due to the relatively low product yields and purity obtained, these authors later elected to
use the procedure reported by Dornow and Bruncken to synthesize the same pyridinyl series in
higher yields and purity (greater than 85%) and used them as standards against the compounds
synthesized via their route. These analogues were distinctly effective against tuberculosis and a
medication was patented based on this research.28 In general, the reaction is enhanced when the
hydrazide is unsubstituted, however, with a bulky substituent, lower yields are observed. This

7

steric effect was reported also by Yale et al. who obtained similar results from the reaction of
substituted hydrazides with dimethylcarbamyl chloride.23

Reactivity of 1,3,4-Oxadiazol-2(3H)-ones
Diels and Okada successfully demonstrated that the ring system of 8 is susceptible to a
ring-opening reaction by nucleophilic attack at the C2 position. Thus, 9 resulted from treatment
of 8 with aniline under reflux (Scheme 9).19 It is apparent that, after the initial nucleophilic attack
at the C2 position, ring opening occurs, followed by enol / keto tautomerization.
Scheme 9: Reaction of 5-phenyl-1,3,4-oxadiazol-2(3H)-one (8) with aniline19

Interestingly, the reaction of anilines with compound 8 at high temperatures had already
been reported by Diels et al. in 1912 although the identities of the products were unknown.19
The oxadiazolinone ring stability was probed by reaction with ammonia and amines at a
variety of temperatures. The ring was completely intact when treated with ammonia at room
temperature but, upon warming to 70-80oC, the corresponding substituted semicarbazide resulted
(Scheme 10).22 It was concluded that higher reaction temperatures promoted ring opening
(revealing a temperature dependence).22
Scheme 10: Reactions of 5-substituted-1,3,4-oxadiazol-2(3H)-ones with ammonia22
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Stempel et al. successfully synthesized 5-substituted-1,3,4-oxadiazol-2(3H)-ones and
then prepared semicarbazides and hydrazides from reactions of the former with a variety of
amines and amine derivatives as shown in Scheme 11.22
Scheme 11: Reactions of 5-substituted-1,3,4-oxadiazol-2(3H)-ones with substituted amines a
moderate to high temperatures

An attack at the C2 carbonyl was observed also with 5-alkoxy-1,3,4-oxadiazol-2(3H)ones using methanol/sodium carbonate, sodium methoxide/methanol or sodium tert-butyl
mercaptide in methanol or THF (Scheme 12).24 Each reaction provided similar results and the
products isolated were characterized as ring-opened materials, akin to those shown in Scheme
12.24
Scheme 12: Chemical reactivity of 3-aryl-5-alkoxy-1,3,4-oxadiazol-2(3H)-ones with sodium
methoxide in methanol24

In 2005, Badami et al. synthesized triazoles via ring transformation of 3-aryl-5-methyl1,3,4-oxadiazolin-2-ones by reaction with hydrazine hydrate and a variety of amine nucleophiles.
The triazoles obtained were subjected to biological studies to determine their utility as antifungal
agents (Scheme 13).25 The mechanism apparently involves initial attack at the C2 carbonyl
followed by ring opening and recyclization from the newly-attached nitrogen atom.
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Scheme 13: Synthesis of triazoles from 3-aryl-5-methyl-1,3,4-oxadiazolin-2-ones25

This type of reaction has been extended to the use of various amines and amine
derivatives as an avenue to substituted triazoles.

Characterization of 1,3,4-Oxadiazol-2(3H)-ones
IR spectroscopy is used to identify the presence of the C=O from the “-lactone” present
in the oxadiazolinone system and the former is typically observed as a sharp peak around 18001700 cm-1. Higher wavenumbers are expected when R” (in 6 below) is an electron withdrawing
group while lower wavenumbers are observed when an alkyl substituent is attached at the C5
position (Figure 2).
1

H NMR has been used extensively to determine the identity of derivatives of 6. In this

thesis many of the synthesized derivatives of 6 have R” = Me or CH2-X. Thus, when R” = Me
the singlet appears around 1-2 ppm and when R” is CH2-Br or CH2-Cl a downfield shift to ~4.14.4 ppm occurs.
13

C NMR confirms the presence of both imine-like and lactone-like features in 6. At the

C5 position the chemical shift is commonly ~149 ppm and the lactone C=O carbon appears
further downfield at ~154 ppm. These values change little regardless of the substitution and are
therefore useful for characterization.
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The stability of oxadiazolinones makes them suitable for GC/MS analysis. The products
can be isolated and analyzed to effectively gauge overall purity and to provide a detailed mass
spectrum for each component separated by GC. The typical fragment pattern observed in our lab.
is first the loss of -CO2 followed by the loss of -N=CR”.

Figure 2. Typical Spectral Characteristics of 1,3,4-oxadiazol-2(3H)-ones

Biological Activity of 1,3,4-Oxadiazol-2(3H)-ones
5-Substituted-1,3,4-oxadiazol-2(3H)-ones possess a variety of biological properties. The
first biological studies of 3-aryl-5-alkoxy-1,3,4-oxadiazol-2(3H)-ones were conducted as early as
1943 by Hansberry,26 then continued by Payne27 in 1966. 3-Aryl-5-alkoxy-1,3,4-oxadiazol2(3H)-ones and derivatives were identified as acetylcholinesterase inhibitors by these
individuals. The first notable animal tests were performed by Grunberg et al. who observed that
5-(4-pyridyl)- and 5-(4-pyridyl)-3-isopropyl-1,3,4-oxadiazol-2(3H)-one derivatives showed
inhibition of M. tuberculosis, in vivo.29 However, due to the need for pesticide alternatives,
researchers have focused on the synthesis of a variety of 1,3,4-oxadiazol-2(3H)-one derivatives
used to thwart pests. Pesticides derived from 1,3,4-oxadiazol-2(3H)-ones are valuable because
they are stable while applied and become active when the pest metabolizes the compound.28
Boesch et al. later discovered that the 5-alkoxy derivatives could be utilized as
anthelmintics and insecticides.28 One such compound was tested in a study, which involved
11

houseflies and measurement of their levels of acetylcholinesterase (AChE-OH) after exposure.
Significant enzymatic inhibitory activity was observed in the houseflies and this compound was
designated as an antiesterase agent.28 The actual molecule bound to the enzyme was identified as
the oxadiazolinone metabolite (Figure 3).

Figure 3. Interaction of 5-alkoxy-3-substituted-1,3,4-oxadiazol-2(3H)-ones with
acetylcholinesterase 24
In further studies, researchers developed 5-substituted-3-aryl-1,3,4-oxadiazol-2(3H)ones, which were as effective as the industry standard but much less harmful to humans.24 The
most common use (today) for 1,3,4-oxadiazol-2(3H)-ones is to thwart insects and invasive plant
species on and around crops. RonstarTM is an example of a commercialized 1,3,4-oxadiazol2(3H)-one herbicide formulation that is produced on the millions of metric tons a year level.30
Previous evidence from numerous biological activity studies supports the contention that
the metabolite of the 1,3,4-oxadiazol-2(3H)-one is responsible for the acetylcholinesterase
inhibitory activity, however, definitive evidence was lacking previously due to technological
restrictions. Huang and Bushey devised an experiment using enzymatic probes, which revealed
that the metabolites rather than the parent drug were enzyme-bound.24
More recently the focus has switched to the development of unique methods for
substituent modification at the 3 and 5 positions of the 1,3,4-oxadiazolone ring system. Different
substituents provide a handle for post-modification of the 5-substituted-1,3,4-oxadiazol-2(3H)ones leading to a diverse array of molecular scaffolds possessing the potential for biological
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activity. The resulting biological activity ranges from antitumoral, anthelmintic, antiviral,
antimicrobial, insecticidal to herbicidal but is not constrained to these effects.
Routes to 1,3,4-Oxadiazol-2(3H)-ones from Sydnones
As mentioned previously, prospective medicinal 1,3,4-oxadiazol-2(3H)-ones have been
sought and researchers have had some success in identifying 1,3,4-oxadiazol-2(3H)-ones
possessing either antitumoral or antimicrobial activity.32 The main bottleneck in this process is
the synthesis and derivatization of these chemical species. Many of the known routes for the
synthesis of 1,3,4-oxadiazol-2(3H)-ones lack versatility because of limitations inherent from the
required starting materials. A current and promising outlet to uniquely substituted 1,3,4oxadiazol-2(3H)-ones is a transformation developed from sydnones. This approach provides
control over both substituents attached at the 3 and 5 positions of the oxadiazolone ring31 and
was first documented in 1958 by Stansfield and has been modified since to yield a diverse
variety of 1,3,4-oxadiazol-2(3H)-ones.
Stansfield observed the formation of 5-alkyl-3-phenyl-1,3,4-oxadiazol-2(3H)-ones while
attempting to repeat the bromination of 3-phenylsydnone at the 4-position using bromine in
acetic anhydride.31 The initial bromination was conducted at ice bath temperature, followed by
warming to 30-60oC. The latter was a deviation from the procedure provided by Baker et al.2 and
led to an interesting result. The product isolated was 5-methyl-3-phenyl-1,3,4-oxadiazol-2(3H)one (6, R = Me) and Stansfield was able to extend this method by changing the acid anhydride
used. Thus, with propionic anhydride and butyric anhydride the corresponding oxadiazolinones
6, R = Et, Pr, respectively, resulted. This process allowed for modification of the substituent
attached at the C5 position of the ring by simply changing the acid anhydride used.
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Scheme 14: Stansfield’s synthesis of 5-alkyl-3-phenyl-1,3,4-oxadiazol-2(3H)-ones31

6c-e

Using the same conditions as reported by Stansfield, Badami extended the method to a
variety of 3-arylsydnones (Scheme 15). Badami obtained high yields of the appropriate 5-alkyl3-aryl-1,3,4-oxadiazol-2(3H)-ones, in high purity, without subsequent purification.32
Scheme 15: Synthesis of 5-methyl-3-aryl-oxadiazol-2(3H)-ones by Badami et. al.32

Badami’s research allowed her to formulate a mechanism for the transformations (shown
in Scheme 16) involving a 1,3-dipolar cycloaddition of the acetic anhydride C=O across the C4
and N2 atoms of the sydnone ring.32 However, hitherto, there have been no 1,3-dipolar
cycloaddition reactions with sydnones reported utilizing such mild conditions or with a carbonyl
group. The most common examples have been with alkynes heated to ~130°C and, accordingly,
Badami’s suggestion seems counterintuitive.
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Scheme 16: Badami’s proposed mechanism for the formation of 5-alkyl-3-aryl-1,3,4-oxadiazol2(3H)-ones from 3-arylsydnones32

A possible alternative mechanistic explanation relies on work from the early 1990’s.
Thus, in 1994, Yeh et al. observed that 4-bromo or 4-chloro sydnones fragmented into
halocarbonyl hydrazines 10 when reacted with a mineral acid in the presence of heat (Scheme
17).6
Scheme 17: Synthesis of halocarbonylhydrazine salts from halogenated sydnones6

Yeh et al. extensively studied the breakdown of the sydnone ring with the use of different
mineral acids.6 Each mineral acid yielded the corresponding salt of the halocarbonylaryl
hydrazine 10 and the halogen substitution (X1) on 10 arose from that in the starting 4-halo
sydnone. Mechanistically, the mineral acid protonates the sydnone ring at the N-2 position,
ultimately catalyzing ring cleavage by water, which leads to extrusion of CO2 and formation of
the hydrazine salt.6 Though not mentioned by Stansfield or Badami, it is a presumption in this
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thesis that 10 plays a major role in the overall mechanism for the formation of 1,3,4-oxadiazol2(3H)-ones.
Further, in support of Yeh’s work and the contention that the sydnone ring is likely to be
cleaved under the conditions reported by Stansfield and Badami, in 1993, Turnbull and Marx33
observed the formation of 1-bromocarbonyl-3-substituted indazoles when 4-bromo-3-(2acylaryl)sydnones were treated with HBr gas (Scheme 18). It seems reasonable to conclude that
the sydnone ring is being cleaved to a bromocarbonylhydrazine derivative (akin to 10) and the
latter then attacks the ortho-carbonyl to generate the indazole system.
Scheme 18: Synthesis of 1-bromocarbonyl-3-substituted indazoles from 4-bromo-3arylsydnones and HBr gas33

Apart from the unprecedented nature of the cycloaddition mechanism, the main issue that
goes unaddressed in Badami’s mechanism (Scheme 16) is that, when the 4-bromo-3arylsydnones are generated, HBr is also formed. If HBr is present and the reaction mixture is
heated, it is extremely likely that the sydnone will be cleaved to the bromocarbonylphenyl
hydrazine salt 10 rather than remain intact and undergo a cycloaddition process.
Given the above data, Turnbull et al. have proposed a mechanism for the sydnone to
oxadiazolinone transformation (Scheme 19) in which the bromocarbonylphenyl hydrazine salt 10
is the key intermediate. Thus, the N-substituted sydnone is first brominated at the 4-position,
HBr is formed in situ and the latter cleaves the sydnone ring to form the intermediate salt. If
enough hydrazine salt is present in the free-base form a reaction can then occur with the
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anhydride. The ring closure is catalyzed by heating the reaction mixture and the 1,3,4-oxadiazol2(3H)-one product is thus obtained.
Scheme 19: Proposed mechanism for the formation of 5-alkyl-3-aryl-1,3,4-oxadiazol-2(3H)ones from 4-halogenated-3-substituted sydnones

The mechanism proposed by Badami32 has some critical flaws and shortcomings which
are addressed in Turnbull et al.’s mechanistic proposal for the formation of 1,3,4-oxadiazol2(3H)-ones from sydnones (Scheme 19).
To further support this alternative mechanism, Gerritsen and Klaasen in the Turnbull lab.
reinvestigated the experimental procedure used by Stansfield31 in 1958 (Scheme 20).
Scheme 20: Reinvestigation of previous procedure for transformation of sydnones to 1,3,4oxadiazol-2(3H)-ones

3, R=H

6a

Their results confirmed the synthesis of the 5-methyl-3-phenyl-1,3,4-oxadiazol-2(3H)one (6a), however, there was also an impurity present in approximately 5-12% yield. After shortpath column chromatography, 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b) was
17

isolated and characterized as the major impurity from the mixture. Gerritsen and Klaasen
optimized the reaction, minimizing the impurity to ~1%, however, they were unable to change
the reaction conditions to provide solely compound 6b as product. When the reaction mixture
was cooled, the relative concentration of 6b in the product mixture increased. Klaasen observed
that using 1.1 molar eq. of bromine in acetic acid provided 6b in high yields and purity,
challenging expectations, since the rate of this process is likely to be temperature dependent. He
showed later that compound 6a could be brominated separately with bromine to give
bromination on the para-position of the phenyl ring; a significant advance, compared to starting
from the appropriately substituted parent sydnone.

6b

Figure 4. Structure and numbering for the “impurity”, 5-(bromomethyl)-3-phenyl-1,3,4oxadiazol-2(3H)-one (6b)
The impurity 6b was unreported in Badami’s papers but was found experimentally in
relatively high quantities by both Gerritsen and Klaasen, raising questions about the veracity of
Badami’s work. Compound 6b is thought to arise from alpha-bromination of acetic anhydride
followed by nucleophilic attack by the bromocarbonyl hydrazine 10 free-base and, finally, by
heterocyclization to the 1,3,4-oxadiazol-2(3H)-one.
To test the suggested mechanism, Madaram in the Turnbull lab. was tasked with
synthesizing the oxadiazolinone “impurity” 6b via reaction of the bromocarbonylhydrazine salt
intermediate with bromoacetyl chloride in 1,2-dimethoxyethane. The salt intermediate was
18

generated following Yeh et al.’s6 procedure from 4-bromo-3-phenylsydnone. Success in the
above approach provided samples of 6b for study in moderate to good yields with relatively high
purity as well as supporting the mechanism suggested in Scheme 19. As a result, Madaram was
able to expand the process by reacting bromocarbonyl hydrazine salts with the appropriate acid
chlorides to give 5-substituted-3-phenyl-1,3,4-oxadiazol-2(3H)-ones (Scheme 21).
Scheme 21: Reaction of bromocarbonylhydrazine salts with acid chlorides

This evidence supports the mechanism proposed by Turnbull et al. in which the hydrazine
salt is considered a crucial intermediate in the formation of 1,3,4-oxadiazol-2(3H)-ones from
sydnones. This project also demonstrated that 1,3,4-oxadiazol-2(3H)-one ring systems could be
assembled utilizing the intermediate bromocarbonylhydrazine and an acid halide in DME. The
latter is a useful modification since there is a greater diversity of acid chlorides available
commercially (as opposed to anhydrides) and the use of a solvent allows smaller amounts of
reagents to be employed compared to the Stansfield process.
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Project Aims
The global aims of the project have been divided into two sections to clearly designate
the research intent for each of the objectives. The over-arching goal of this research project was
to improve the synthesis and study the reactions of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol2(3H)-one (6b). The end-goal of the study was to functionalize compound 6b in a fashion
allowing for molecular diversification at up to 3 sites (Scheme 22).
Scheme 22: Representation of global project aims
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Synthesis and Reactivity of 5-(Bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b)
The primary objective was to optimize the synthesis of 6b and then perform reactions in
attempts to isolate derivatives thereof, via reaction with electrophilic and nucleophilic substrates.
Scheme 22 considers the reactions of both electrophiles and nucleophiles with compound 6b. In
an ideal situation, the nucleophile will react selectively, displacing the bromine atom to provide
an appropriately substituted oxadiazolinone. In the scenario considering the reaction of 6b and an
electrophile, the optimum electrophilic substrate was considered to be one which added para to
the 1,3,4-oxadiazol-2(3H)-one ring in a selective and controlled fashion.
The diagonal pathways shown in Scheme 22 are contingent on the overall success of the
proposed horizontal pathways. If a nucleophile and/or an electrophile add in the desired fashions,
the same reactions should be applicable to the products of the horizontal schemes as potential
routes to 5-substituted-3-aryl-1,3,4-oxadiazol-2(3H)-ones bearing 2 sites of diversification
(newly attached substrate at C5 and newly attached substrate at the aryl para position). Further
manipulation of these functional groups may be achievable though a variety of chemical
transformations, leading to highly diverse, 5-substituted-3-aryl-1,3,4-oxadiazol-2(3H)-ones. The
3rd site of diversification (C=O of lactone) should then be accessible by a strong nucleophile (e.g.
methoxide or ethoxide) causing ring-opening of the 1,3,4-oxadiazol-2(3H)-one to form a
substituted hydrazide.
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Chlorination of 3-Arylsydnones with Iodine Monochloride in DCM and Subsequent
Synthesis of 5-Methyl-3-aryl-1,3,4-oxadiazol-2(3H)-ones from 4-Chloro-3-arylsydnones
Previous work in our lab had shown that when a sydnone was treated with ICl in DCM as
solvent, in contrast to the result using acetic acid as solvent, from which the iodinated product
was isolated, a mixture of both chloro and iodo products resulted (Scheme 23).34
Scheme 23: Chlorination of 3-arylsydnones followed by attempted transformation to 5-methyl3-aryl-1,3,4-oxadiazol-2(3H)-ones

Since the chlorosydnone was the major product it was of interest to re-explore the
reaction and modify the conditions with the expectation that the process could be optimized to
yield only the 4-chloro species. If successful, the resultant chlorinated sydnones would be
subjected to reaction with acetic anhydride in acetic acid with the expectation that 5-methyl-3aryl-1,3,4-oxadiazol-2(3H)-ones would result. In this regard, previous work had shown that the
latter species form directly from sydnones or intermediates thereof using acetic anhydride as the
solvent, however, since the latter was both solvent and reagent, improvement of the process was
essential. The key parameter changes would be to utilize acetic acid as solvent, reduce the
amount of acetic anhydride and modify the reaction temperature.
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It was recognized that optimization of this procedure was not necessarily contingent on
the successful chlorination of 3-arylsydnones with ICl in DCM, since other routes to chlorinated
sydnones are currently available. Thus, if the chlorination using ICl were to be unsuccessful, 4chloro-3-arylsydnones would be synthesized utilizing one of the other available methods, still
allowing exploration of the viability of the new route to 5-methyl-3-aryl-1,3,4-oxadiazol-2(3H)ones.
Results and Discussion
Optimization for the Synthesis of 5-(Bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
(6b)
Since 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b) was to be a key part of
the present research, it was important to develop the most efficient avenue to its synthesis.
Initially, Madaram’s previously reported reaction conditions for the synthesis of the
bromomethyl species 6b [Scheme 21] were utilized to generate a baseline for the product identity
and composition using GC/MS. In each case, where bromoacetyl chloride (BAC) was used, there
was a common trend in the product composition, viz. the target material was typically present as
the major component along with two other very similar components (Scheme 24). From further
study it became apparent that the byproducts (11 and 12) arose from impurities in the
bromoacetyl chloride reagent used to convert the salt into the oxadiazolinone ring system. Thus,
the reagent (purum) is typically 98% pure and the other 2% is comprised of chloroacetyl chloride
and iodoacetyl chloride; the latter react with the intermediate bromocarbonylhydrazine salts to
yield the observed impurities, 11 and 12 (Scheme 24). Accordingly, changes in time,
temperature, starting material and the bromoacetyl halide reagents were investigated in order to
minimize the byproduct composition relative to the target material (Scheme 26, Tables 1, 2).
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Further, this optimization helped to determine which of the bromoacetyl halide / bromocarbonylphenyl hydrazine salt combinations provided the target molecule with the highest yields and
purity.
Scheme 24: Reaction of bromocarbonylphenylhydrazine salts with bromoacetyl chloride

6b

The procedure shown in Scheme 24 was conducted to gather information on the product
distributions generated from this reaction. The products of these reactions were subjected to
GC/MS analysis to accurately assess the relative distribution between the 3 expected products.
The presence of 5-(chloromethyl)- 11 and 5-(iodomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
(12) was confirmed by the mass spectrum provided after GC separation of each component and
the parent ions were identified as 210 and 302, respectively. A melting range for each impure
product mixture was obtained to determine which procedure provided a product closest to the
literature melting point of 6b, viz. 80-81°C. Further, the identity of 11 was confirmed by
synthesis (Scheme 25). Thus, reaction of chloroacetyl chloride (CAC) with bromocarbonylphenyl hydrazine hydrochloride 10b provided 11, which was characterized by its spectral
properties and provided a GC signal / mass spectrum identical to the by-product present in the
original reaction (Scheme 24).
Scheme 25: Synthesis of 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (11)

10b
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In an attempt to reduce the relative concentration of 11 and 12 in a crude sample of 6b, as
shown in Scheme 24, bromoacetyl bromide (BAB) was employed to determine if changing the
leaving group in the acid halide from chlorine to bromine would have a positive effect (Scheme
26). The reactions involving BAB provided impure product mixtures, which were obtained in
relatively low yields. However, while BAB reduced the yields, the purity of the mixture slightly
improved since BAB is comprised of 98% bromoacetyl bromide and 2% chloroacetyl bromide.
The results of each reaction involving BAB are reported in Table 2.
Scheme 26: Reaction of 10a and 10b with bromoacetyl bromide

6b

10a or 10b

The other key implementation to this attempted optimization was to consider which
bromocarbonylphenylhydrazine salt, 10a or 10b, would be most effective as the starting material
by exploring the other parameters associated with the reaction, such as temperature, time and
stoichiometry (Tables 1, 2).
Table 1. Hydrobromide (10a) and hydrochloride (10b) hydrazine salt reactions with BAC

S.M.

10b

Acyl Halide

Bromoacetyl
Chloride

Stoichiometry
Temp.
(mol. eq. acyl
(°C)
halide)

Time Yield
(h)
(%)

1

65

3.5

66

1

45

3.5

79

1

65

1

69
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GC/MS
11.593% (11),
88.407% (6b)
2.97% (11),
2.38% (12),
94.65% (6b)
0.926% (11),
98.174% (6b),
0.899% (12)

m.p.
(°C)
61-69
60-65
7575.5

10a

1.5

65

1

88

1.5

65

1.1

78.4

1.5

65

1.5

73

1.5

70

1

87

1.5

75

1

90

1.5

60

1.15

80

1.4

60

1

79

1.3

60

1

83

1.2

55

1

76

1.2

60

1

78

1

65

3.5

51

1

45

3.5
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Bromoacetyl
Chloride

1.644% (11),
97.708% (6b),
0.648% (12)
0.903% (11),
1.257% (6b),
97.840% (12)
5.550% (11),
94.004% (6b),
0.446% (12)
9.323% (11),
90.677% (6b)
7.629% (11),
91.293% (6b),
1.877% (12)
9.314% (11),
89.594% (6b),
1.091% (12)
4.348% (11),
93.975% (6b),
1.676% (12)
2.644% (11),
95.696% (6b),
1.668% (12)
1.615% (11),
97.751% (6b),
0.634% (12)
1.529% (11),
97.306% (6b),
1.165% (12)
1.650% (11),
97.207% (6b),
1.186% (12)
0.772% (11),
97.809% (6b),
1.418% (12),

7979.5
7979.5
7979.5
77-79
76-77
79.580
78-79

78-79

78-79

77-79

70-76

70-73

The first entry in Table 1 reports the results obtained by repeating the procedure reported
by Madaram for the synthesis of 6b from 10b. The yield from this process was relatively low and
provided 6b as ~88% of the product mixture. The other product present in the mixture was 11. To
monitor the effects of reducing the temperature, the same parameters were maintained except
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that the reaction was conducted at 45°C for 3.5 hours to provide a 79% crude yield, with ~94%
of 6b, and no improvement in the melting point range. The next entry shows the result of using
the higher temperature but reducing the reaction time from 3.5 hours to 1 hour. While this
procedure provided similar yields to the previous two experiments, the amount of impurity was
reduced to less than 2% of the product mixture and the crude melting point was improved
considerably.
Using these newly optimized time and temperature parameters, it was elected to explore
the effects of an increase in the molar equivalents of BAC from 1 to 1.5 eq. The next table entry
shows that this increase improved both the overall crude yield (88%) and the melting point of the
crude product (79-79.5°C). Increasing the temperature, while maintaining the use of 1.5 mol. eq.
BAC, did provide 6b as ~90% of the product mixture in high yield, however the slightly
depressed melting point (76-77°C) compared to the previous entry is indicative that the product
purity has decreased slightly, which agrees with the product composition as reported by GC/MS.
Increasing the temperature appears to accentuate the relative concentration of the impurities,
therefore, no further increased temperature reactions were performed.
In the next table entries, the molar equivalents of BAC were altered from 1.5 to 1 eq., by
tenths of an equivalent, in attempts to reduce the amount of BAC used. For each reaction in
which the mol. eq. of BAC was reduced, an increase in overall product purity was observed. The
by-products remained present in the reaction material as minor impurities, which suggested that
the temperature of the system could be affecting the overall byproduct distribution (up to ~10%
minor components). Accordingly, the reaction temperature was lowered from 65°C to 55°C,
reducing the total byproduct distribution, relative to the desired product, to ~2%.
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From these studies, it was determined that the optimum reaction conditions were 1.2
molar eq. of BAC at 55°C for 1 h. Moderate to high yields of 6b were obtained from the fully
optimized procedure (Scheme 27). Duplicates of the reaction were performed to ensure that the
reported composition was accurately represented and, in general, the impurities were minimized
to no more than 2% of the final product composition.
Scheme 27: Fully optimized synthesis of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

6b

The final two entries in Table 1 were conducted using similar conditions to those reported
in the first two entries, except that the hydrobromide salt 10a was employed as the starting
material. The yields from each of these reactions decreased relative to those with 10b and the
melting point ranges of their individual products broadened, although the GC/MS results
suggested that 6b was nearly 98% of the product mixture. The GC/MS data seem to incorrectly
represent the overall purity of the product mixture obtained for the final two entries, given the
reduced and broadened product melting points and, accordingly, these procedures were no longer
pursued as avenues to 6b.
Further work was executed using BAB with 10a and 10b to investigate whether or not
the product yields and purity would increase with the modified leaving group (Scheme 26)
[Table 2].
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Table 2. Hydrobromide (10a) and hydrochloride (10b) hydrazine salt reactions with BAB

S.M.

10b

10a

Acyl Halide

Bromoacetyl
Bromide

Bromoacetyl
Bromide

Stoichiometry
Temp. Time Yield
(mol. eq. acyl
(°C)
(h)
(%)
halide)
1

65

1.5

56

1.5

65

1

75

1.5

70

1

37.9

1

65

3.5

48

m.p.
(°C)

GC/MS
3.038% (11),
95.916% (6b),
1.046% (12)
1.50%(11),
0.80% (12),
97.70% (6b)
99.30% (6b),
0.70 (11)
1.6% (11),
98.6% (6b),
1.6% (12)

64-66

74-76
69-73
72-73

When 10b was reacted with 1 molar eq. of BAB at 65°C for 1.5 h. the yield and purity of
the product 6b were poor, supported by the low melting point and the GC/MS data. When the
molar equivalents of BAB were increased to 1.5, the purity of the product mixture improved
(according to GC/MS and the m.p,), however, the melting point of the product was still low
relative to the results reported in Table 1. Increasing the temperature to 70°C lowered the yield
considerably. Similarly, when 10a was reacted with a single molar eq. of BAB, the product yield
was poor and the purity, as assessed by melting point, was relatively low. This method provided
low yields and the overall purity decreased compared to when the BAC was utilized along with
both 10a and 10b.
Bromoacetyl bromide provided 6b in relatively low yields and purity, however, when
bromoacetyl chloride was used (Scheme 27) the quality of the product and the yields improved
significantly. The salt that exhibited the highest purity products and yields in the baseline
reactions series was 10b in reaction with bromoacetyl chloride. The stoichiometry of the acid
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halide was lowered from 1.5 equivalents to 1.2 equivalents and the reaction time was reduced to
approximately 1 hour from 3.5 hours to provide 6b in the best combination of purity and yield.

Synthesis of 5-(Trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (13)
A synthetic route to compound 13 was pursued to assess if bulky, strongly electronwithdrawing substituents could be attached at the C5-position using similar reaction parameters
to those shown in Scheme 27. Trichloroacetyl chloride is readily available and, unlike the
previous acetyl chlorides used in Schemes 24-27, could be purchased in ≥99% purity. This
reagent was selected because the 5-trichloromethyl substituent in 13 is extremely electron
withdrawing and could potentially affect the electronics of the ring system. A trichloromethyl
group can be susceptible to nucleophilic substitution, meaning that it might then be possible to
functionalize 13 even further. The trichloroacetyl chloride is a much more electrophilic reactant
than acetic anhydride (or the previously used acetyl chlorides) and, as a result, it was anticipated
that reaction with the bromocarbonylhydrazine free base would be enhanced but the subsequent
cyclization might be slowed due to a combination of electronic and steric effects. Accordingly,
after initial reagent addition the reaction temperature was increased to counteract any such
possibilities. By varying the stoichiometry, reaction time and temperature it was possible to
prepare the desired 5-trichloromethyl species 13 in high yield and purity (Scheme 28) [Table 3].
Scheme 28: Synthesis of 5-(trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (13)
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Table 3. Optimization parameters and changes for the synthesis of 13
Entry
#
1
2
3
4
5

Stoichiometry
(mol. eq. acyl
halide)
1
1.5
1.5
1.1
1.5

Temp.
(°C)
65
60
65
70
70

Time (h)
1.5
16
1.5
2
1.5

Yield (%)
68
75
74
65
94

Melting Point
(°C)
97-99
100-102
107-108
105.5-106.5
108-109

When 1.1 eq., or an equimolar amount of reagent, was employed, relatively lower yields
and purity in the final product were observed. However, with 1.5 equivalents of reagent, the
reaction seemed to proceed swiftly at higher temperatures (entries 3 and 5), providing better
yields and purity. The effects of temperature optimization were examined also, since it was
expected that higher temperatures would be necessary to overcome possible steric hindrance /
electronic effects and improve the overall yields. The temperatures used in this case ranged from
60-70°C and it was found that a temperature of 70°C and reaction time of 1.5 hours provided the
best results. When the temperature was reduced to 60°C, the rate of formation of the product was
slowed, therefore, the time parameter was increased. After 16 h, the reaction mixture by TLC
appeared to be a single spot with a different Rf than the starting material 10b. The final reaction
in Table 3 utilized 1.5 molar eq. at 70°C for 1.5 hours. These conditions appear to be optimum,
providing an overall product yield of 94% with a sharp melting point (108-109°C). While this
was not tested, it is anticipated that the optimizations developed above could be utilized in a
general method for the synthesis of 5-substituted-3-aryl-1,3,4-oxadiazol-2(3H)-ones where the 5substituent is bulky, strongly electron-withdrawing or both.
The product, 13, was obtained as long, colorless, translucent crystals and was identified
by its spectral characteristics as well as from a satisfactory elemental analysis. Thus, the FT-IR
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spectrum displayed the carbonyl stretch of the lactone at 1793.35 cm-1 as a sharp narrow peak
with no other substantive IR evidence observable. The 1H NMR spectrum displayed the aromatic
protons as a triplet of triplets at 7.33  (1H)a triplet of triplets at 7.48 and a doublet of
triplets at 7.85The 13C NMR spectrum showed peaks at 82.99 ppm (C-CCl3), 118.72
ppm, 127.16 ppm, 129.42 ppm, 135.18 ppm, 149.37 ppm (C=N) and 151.41 ppm (C=O). Finally,
a satisfactory elemental analysis was obtained (Table 4), which provided support for the structure
as 13.
Table 4. Elemental analysis for 5-(trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (13)
Atom
C
H
N

Theory
38.67
1.80
10.02

Found
38.68
1.90
9.82

Dinitration of 5-(Halomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-ones 6b and 11
As mentioned earlier, Gerritsen and Klaasen in the Turnbull lab. demonstrated previously
that nitration of 5-methyl-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6a) yielded the para-nitro
product 14 as the major component in the presence of relatively small amounts of the ortho-nitro
15 and dinitro 16 products (Scheme 29). Pure 14 could be obtained by recrystallization from
95% ethanol, albeit in modest yield (~40%).
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Scheme 29: Reaction of 5-methyl-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6a) with KNO3 in
H2SO4

14

6a

15

16

It was anticipated that the nitro compound (and similar molecules) could be postmodified and, to this end, Klaasen reduced 14 to the amine 17, however, the process used
resulted in rather low yields (Scheme 30).
Scheme 30: Reduction of 5-methyl-3-(4-nitrophenyl)-1,3,4-oxadiazol-2(3H)-one (14)

17

14

In the current work, it was elected to extend Klaasen’s procedure to the nitration of 5(bromomethyl)- and 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-ones. The first attempts
to mononitrate the bromomethyl compound 6b with 1.1 equivalents of nitrating agent were
unsuccessful and provided product mixtures comprised of 3 components (speculated to be 18, 19
and 20; Scheme 31). In contrast to Klaasen’s reaction with 6a, the product mixture from the
reaction of 6b contained more substantial amounts of the by-products and, accordingly, the
desired product 18 was unable to be recrystallized from the product mixture using 95% ethanol.
Further, the similarity in polarity of each component made the mixture inseparable by traditional
column chromatographic methods.
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Scheme 31: Nitration of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b)

Table 5 shows variations of this experiment where the KNO3 addition duration was
decreased with a view to improving the yield of 18. The results of decreasing the KNO3 addition
duration significantly reduced the relative concentrations of both 19 and 20 in the crude product
mixtures. Lowering the reaction temperature to ~ -10°C and a long addition duration of KNO3
for each reaction shown in Table 5 completely impeded the reaction pathway to 20, but permitted
competition between the formation of 18 and 19.
Table 5. Attempted mononitration of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
Entry
#

Addition
Duration
(min)

Time (h)

Yield (%)

Melting
Point (°C)

Product(s)

1
2
3

15
30
60

2
2
3

78
86
97

oil
oil
(l) at RT

18, 19, 20
18, 19
18, 19

The first entry in Table 5 shows the reaction of 6b with 1.1 mol. eq. of KNO3 for 2 hours
at 0°C. This reaction provided an impure product mixture of 18, 19, and 20 in relative yields of
5.2%, 87.4% and 5.8%, respectively. In addition, 1.6% of the starting material was present. It
was surmised that the rapid addition of KNO3 in entry 1 of Table 5 led to the formation of 20 and
it seemed likely that a longer reaction time would be required to ensure complete consumption of
the starting material. Evidence from entry 1 of Table 5 suggests that the reaction time of 2 hours
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is a suitable amount of time to form species 18 and 19, however, to impede the formation of 20 it
was determined that the addition of KNO3 should be lengthened.
The second entry in Table 5 maintains all other parameters with the sole modification
being the duration of the KNO3 addition. The reagent was added over a period of 30 minutes,
providing a 2-component product mixture (18 and 19, 8.8% and 83.7%, respectively, GC/MS)
with some unreacted starting material present (4.4%). From this evidence, the previous rapid rate
of addition may have contributed to the formation of the dinitro species. Therefore, the reaction
time was increased from 2 h to 3 h in entry 3 of Table 5 in an attempt to consume all of the
starting material and the duration of KNO3 addition was further lengthened to a period of 1 h.
GC/MS data for the product mixture obtained from the final entry of Table 5 indicated that the
product was composed of two components (87% major and 13% minor), however, these results
may be unrepresentative of the sample purity since the product obtained is a liquid and does not
crystallize upon cooling. Indeed, when this product mixture was subjected to TLC examination
(Figure 4), there were 3 components present (18, 19, and 6b), another indicator that the GC/MS
results may be misleading. The impure oily mixture could not be recrystallized using 95%
ethanol and it also proved impossible to separate each component by column chromatographic
methods, primarily due to the similarity in the Rf values for each component (Figure 5).

Figure 5. TLC representation of entry 3 of Table 5, showing the presence of 2 products and a
single component with the same Rf as the starting material.
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Due to the difficulty encountered when trying to mononitrate 6b, a different avenue was
taken. Thus, as mentioned previously, (Scheme 31), the dinitro compound 20 was identified as a
minor product upon attempted mononitration of the bromomethyl species 6b and, accordingly, a
study of dinitration optimization was undertaken. Thus, the amount of KNO3 used in the reaction
with compound 6b was increased 3-fold to 3.3 equivalents and the reaction temperature was
varied in an attempt to dinitrate completely (Scheme 32; Table 6).
Scheme 32: Dinitration of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b)

20

6b

Table 6. Temperature effects on dinitration of 6b

Entry #

Temperature
(°C)

Time (h)

Yield (%)

Melting Point
Crude Product
(°C)

1

0

1.5

86

122-123

2

-5

1.5

89

110-114

3

-15

1.5

96

106-107

Table 6 shows the temperature parameter changes, percent yields and melting points for
the compounds obtained as a result of the temperature changes. Klaasen’s procedure was
modified using 3.3 eq. of KNO3 as opposed to 1.1 eq. The first reaction in Table 6 was conducted
at 0°C and after 1.5 hours provided a high yield and purity of 20. Entries 2 and 3, where the
reaction temperature was lowered, provided higher yields but at a cost of product purity, as
evidenced by the lower product melting points. GC/MS analyses identified 18 and 19 in the
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product mixtures of the final two entries in Table 6. Thus, the optimized procedure for the
synthesis of 20 from 6b appeared to be using the conditions reported in Entry 1, Table 6.
This protocol provided product 20 as a pure sample after recrystallization in high yield (86%).
Yellow-orange spherulites were obtained, with a sharp melting point of 122-123°C. The FT-IR
spectrum identified the carbonyl of the lactone at 1800.34 cm-1 as a sharp, narrow peak and the
NO2 peaks were sharp peaks located at 1343.67 cm-1 and 1541.11 cm-1. The 1H NMR spectrum
displayed the methylene protons at 4.30 the aromatic protons as an o-split doublet at 8.45 an
o- and m-split doublet of doublets at 8.578 and a m-split doublet at 8.20 The 13C NMR
spectrum revealed peaks at 16.97 (CH2-Br), 121.49, 126.12, 127.99, 132.22, 142.29 [C-(p-NO2)],
146.16 [C-(o-NO2)], 149.61 (C=N) and 154.35 (C=O) ppm, in line with expectation.
As an extension of this process, the chloromethyl compound 11 was subjected to this
procedure with the expectation that it would react in a similar fashion to 6b and provide 5(chloromethyl)-3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one (21) [Scheme 33].
Scheme 33: Dinitration of 11 with 3.3 equivalents of KNO3

21

Indeed, the reaction proceeded as expected and provided 21 in high yield (94%) and
purity. Tan-yellow crystallites were obtained, possessing a sharp melting point (m.p. 108-109°C).
The FT-IR spectrum identified the carbonyl of the lactone at 1801.74 cm-1 as a sharp, narrow
peak and the NO2 peaks were sharp peaks located at 1347.07 cm-1 and 1545.28 cm-1. The 1H
NMR spectrum displayed the methylene protons at 4.50 while the aromatic protons were
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observed as an o-split doublet at 8.05 an o- and m-split doublet of doublets at 8.59 and a msplit doublet at 8.87 The 13C NMR spectrum revealed peaks at 33.64 (CH2-Cl), 121.50,
126.16, 128.01, 132.21, 142.30 [C-(p-NO2)], 146.20 [C-(o-NO2)], 149.61 (C=N) and 154.10
(C=O) ppm, as expected for compound 21. A satisfactory elemental analysis was obtained and
the results are shown in Table 7.
Table 7. Elemental analysis results found for compound 21
Atom
C
H
N

Theory
35.96
1.68
18.64

Found
35.84
1.71
18.45

A general procedure is proposed for the future on the basis of the successful dinitration of
both 6b and 11 to form 20 and 21 (Scheme 34).
Scheme 34: Dinitration of 5-(bromomethyl)- and 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol2(3H)-ones

X = Br (6b); X= Cl (11)

X = Br (20); X = Cl (21)
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Reactions of Nucleophiles with the 5-(Bromomethyl)- (6b) and 5-Chloromethyl- (11)
Species
Reactions of Alkoxides with 5-(Bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b)
In previous work, Huang and Bushey reported reactions of 5-methoxy-1,3,4-oxadiazol2(3H)-ones possessing ethyl and phenyl substituents at the N-3 position of the oxadiazolinone
ring with sodium methoxide.24 The reaction between oxadiazolinones and acetylcholinesterase
was modeled by reacting the oxadiazolinones with sodium methoxide in methanol at room
temperature, resulting in ring-opened substrates. This result was expected for these compounds
because the carbonyl of the lactone is the only site vulnerable to nucleophilic attack. Real time
NMR studies were utilized to monitor the reaction from start to finish. The key indicator from
this technique is a signature enhancement of the signal corresponding to the C of the newly
bound methoxy functional group. With this technique, a ring opening half-life for the starting
materials analyzed could be approximated by capturing NMR snapshots of the reaction over its
duration.3 Alkyl oxadiazolinones (7 h) undergo ring opening twice as fast as 3-aryl
oxadiazolinones (14 h) based on the compared half-life approximations.
In the present work, various alkoxides were reacted with 6b, even though previous
research had shown that sodium methoxide reacted readily with the lactone C=O of various
oxadiazolinones. Since compound 6b has two potential sites for nucleophilic attack, and the 5methoxy-3-substituted-1,3,4-oxadiazol-2(3H)-ones studied by Huang and Bushey possessed only
a single site, it was felt that the alkoxide reactions were still of interest. Accordingly, sodium
methoxide, sodium ethoxide and sodium t-butoxide were reacted with 6b in an attempt to
displace the bromine atom via an SN2 process (Scheme 35). While it was hoped that bromine
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displacement would occur in each case, it was anticipated that the best chance of so doing would
be with the bulky t-butoxide.
Scheme 35: Reactions of 6b with alkoxides in the appropriate alcohol

6b

In each case, column chromatography was performed to isolate the major components
from the minor. However, when the major components were isolated from the product mixtures
they still possessed impurities, confirmed by TLC. The columned fractions containing (mostly)
the major product were subjected to GC/MS analysis in an attempt to obtain a well-resolved
mass spectrometry breakdown pattern. The major products shown in Scheme 35 were proposed
on the basis of the M+/W of the parent ion and the breakdown pattern analyzed from the MS
data. In the event, sodium methoxide and ethoxide apparently reacted only at the C=O of the
lactone contained in the oxdiazolinone ring to yield the corresponding hydrazido esters. When
the reaction was performed with 6b and sodium t-butoxide, no reaction was observed when the
process was conducted at room temperature and, accordingly, the procedure was run in a
pressure tube at 80°C instead. After 24 h, TLC examination revealed that no reaction had taken
place. The solvent tert-butyl alcohol has a boiling point of ~82°C therefore the temperature could
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no longer be increased without compromising the integrity of the pressure tubes available in the
lab. and, accordingly, the reaction was not studied further.

Synthesis of 5-(Azidomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (22)
The synthesis of 22 was predicated on an alternate approach to the diversification of
compound 6b by focusing further on the SN2 possibilities of the alkyl halide attached at the C5position. The underlying goal was to synthesize 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol2(3H)-one (22) and then attempt a Staudinger reduction to yield an amino product 23 with an
additional site of diversification (Scheme 36).
Scheme 36: Synthesis of 22 from 6b followed by Staudinger reduction to 23

Huang and Bushey reported ring-opening reactions with alkoxide derivatives at the C2
position of 5-alkoxy-1,3,4-oxadiazol-2(3H)-ones. On the basis of their results, in the present
work t-butoxide was selected as a bulky nucleophile in the hope that it would react selectively at
the methylene carbon of compound 6b. Unfortunately, as mentioned previously, the starting
material was recovered unreacted and no reaction at the C2 position was observed. Nonetheless,
selective SN2 reactions can often be accomplished by selecting an appropriate nucleophile
bearing an affinity for the desired site of substitution. The main goal in the present work was to
select a nucleophile that is capable of reacting selectively at the C5 methylene carbon attached to
the oxadiazolinone ring. The following procedural generation and subsequent optimization was
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conducted to evaluate the relative reactivity of 6b with “soft” nucleophiles compared to “hard”
nucleophiles, like alkoxides.35
Before continuing, the essence of hard/soft nucleophiles must be introduced briefly. The
reason that nucleophiles are termed hard or soft is to indicate their relative reactivity with a
particular electrophilic substrate. The rule states that “hard” nucleophiles prefer an attack on
electrophilic substrates with “hard” sites, while the “soft” nucleophiles attack “soft” sites.
According to hard and soft Lewis acids and bases theory (HSAB), “hard” nucleophiles have a
small atomic radius, are highly charged and are weakly polarizable. “Soft” nucleophiles,
according to HSAB, have a large atomic radius, low charge states and high polarizability. Soft
nucleophilic reactions are kinetically controlled in the sense that they are potentially less
spontaneous and more reversible compared to “hard” nucleophilic reactions, which are typically
thermodynamically controlled. Therefore, NaN3 was selected as a “soft” nucleophile in the hope
that this would avoid nucleophilic attack at the lactone C=O of the 1,3,4-oxadiazol-2(3H)-one
heterocycle.35
Table 8 shows various parameter modifications, overall percent yields and the melting
points of the products obtained from the reaction of 6b with sodium azide. Initially, the
conditions shown in the first entry of the table were used to generate a “pilot” procedure for the
synthesis of 22. Gratifyingly, this first attempt proceeded completely at 50°C after 4 h, providing
an overall product yield of 96% with a melting point of 61-63°C.
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Table 8. Reaction parameter modifications for synthesis of 22
Entry #

Stoichiometry
(mol. Eq. Azide)

Temperature
(°C)

1
2
3
4

1
1
1.1
1.1

50
80
80
80

Time
(h)

Yield
(%)

Melting
Point

4
1.5
2.5
2

96
85
78
80

61-63
64-64.5
65-65.5
67-68

However, even though this approach worked well, the stability of the isolated product 22
stimulated the use of a higher temperature; employed with the expectation that the reaction
would proceed even more rapidly. Accordingly, the remaining entries in Table 8 were performed
at 80°C (EtOH reflux), which reduced the time required for full conversion to product and
provided purer samples, as evidenced by the product melting points.
The second reaction in Table 8 was complete in ~1.5 h. and provided 85% of the expected
product with a sharp and improved melting point of 64-64.5°C.
In entry 3 of Table 8, the reaction time was slightly increased to 2.5 h while the amount
of reagent was increased to an excess of 0.1 molar equivalents. This modification affected the
yield negatively (78%) but improved the product purity further (m.p. 65-65.5°C). Similar results
were observed when the reaction time was reduced to 2 h, however, the yield slightly improved
to 80%. The melting point of the product from entry 4 in Table 8 (67-68°C) suggested that the
purity of the product was greatest via this optimized procedure.
The selection of a soft nucleophile allowed for successful displacement of the bromine
attached to the methylene carbon unit without competitive attack at the C2 carbon. Although the
yield slightly trends downward with optimization attempts, the melting point increases indicate
that product purity has improved. This method was later applied to the corresponding
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chloromethyl species 11 with success (Scheme 37); however, the reaction time had to be
extended and the molar equivalents of NaN3 employed were increased to 1.5 to ensure that all
starting material was consumed. This avenue was particularly useful when impure samples of 6b,
containing 11 and 12, were reacted with sodium azide to provide a single product identified by
TLC and GC/MS. Compound 6b is typically recrystallized from 95% ethanol with only minor
improvement in the product purity but with a considerable loss of material. Using the impure
samples of 6b with this process bypasses the purification of 6b and provides an efficient route to
22, improving the overall yield for the reported procedure.
For further study, 11 was synthesized from chloroacetyl chloride, which is ~99% pure,
inexpensive and commercially available. The reactions of impure 6b with sodium azide proved
that the chlorine, bromine and iodine atoms could be successfully displaced by azide ion and,
therefore, the procedure shown in Scheme 37 was proposed, involving reaction of 11 with
sodium azide in an attempt to maximize product yield and purity.
Scheme 37: Synthesis of 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (22) from 5chloro-3-phenyl-1,3,4-oxadiazol-2(3H)-one (11)

22

The reaction proceeded as expected and provided 22 in high yields (~80%) and purity
(m.p. 67-68°C). Sharp white crystallites were obtained and full spectral characterization was
performed. The FT-IR spectrum identified the carbonyl of the lactone at 1785.57 cm-1 as a sharp,
narrow peak and characteristic, sharp azido absorptions were observed at 2113.44 cm-1 and
2194.18 cm-1. The 1H NMR spectrum allowed identification of the methylene protons at 4.33
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while the aromatic protons were observed as a triplet of triplets at 7.29 a triplet of triplets at
7.46 and a doublet of triplets at 7.84The 13C NMR spectrum revealed peaks at 45.20 ppm
(CH2-N3), 118.33 ppm, 126.51 ppm, 129.29 ppm, 135.60 ppm, 150.05 ppm (C=N) and 151.43
ppm (C=O). The results of an elemental analysis performed on the compound were within
acceptable values if corrected by adding a 1/4 molecule of ethanol to the molecular formula (MF:
C9H7N5O2 • ¼ EtOH).
Table 9. Elemental analysis for 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (22)
Atom
C
H
N

Theory
49.77
3.25
32.25

Found
49.81
3.47
31.92

Synthesis of 5-(Thiocyanomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (24)
The reaction of 6b with ammonium thiocyanate was pursued in an attempt to form
another, potentially useful 5-functionalized 1,3,4-oxadiazol-2(3H)-one, viz. the thiocyanomethyl
species 24 (Scheme 38). Ammonium thiocyanate was selected as a nucleophile for this study
because it has been determined as a “soft” nucleophile, according to HSAB theory.34 This
nucleophilic species was expected to react selectively with the alkyl bromide attached at the C5position, however, a feature of ammonium thiocyanate is that it is an ambident nucleophile and,
as such, it would have the ability to attack through either N or S depending on the reaction
conditions (e.g. solvent, time and temperature), potentially yielding a thiocyanate or
isothiocyanate product [Scheme 38].
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Scheme 38: Potential pathways for the reaction of 6b with ammonium thiocyanate

6b

Fortunately, there is a way to distinguish which atom has committed the nucleophilic
attack using spectral characterization of the product. Using IR spectroscopy, the thiocyanate (RSCN) absorption is typically observed as a sharp peak around or above 2150 cm-1 while the
isothiocyanate (R-NCS) absorption is displayed below ~2150 cm-1 as a sharp peak. In its 13C
NMR spectrum the thiocyanate carbon signal appears ~110 ppm while the isothiocyanate carbon
is typically observed around 125 ppm.
The first reaction of 6b with a 0.1 molar excess of ammonium thiocyanate at room
temperature was successful but provided relatively low yields of the product after 1 h, potentially
due to the relatively small amount of reagent that was used. In the optimized procedure, the
amount of the thiocyanate was increased from 1.1 to 1.5 eq. and this slight modification
increased the yield (91%) and improved the purity of the product obtained (Table 10).
Table 10. Optimization parameters for synthesis of 5-(thiocyanomethyl)-3-phenyl-1,3,4oxadiazol-2(3H)-one (24)

Entry #

Stoichiometry
(mol. eq. -SCN)

1
2

1.1
1.5

Time
(h)
1
6
46

Yield
(%)
72
91

Melting Point
(°C)
111-112
113-114

Scheme 39: Optimized synthesis of 5-(thiocyanomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

6b

24

The reaction proceeded as expected and provided 24 in high yields (~91%) and purity
(m.p. 113-114°C). Sharp, white crystallites were obtained and full spectral characterization was
performed. The FT-IR spectrum displayed the carbonyl of the lactone at 1781.51 cm-1 as a sharp,
narrow peak. The characteristic sharp thiocyanate absorption was observed at 2165.53 cm-1
indicating that the sulfur was bonded to the methylene carbon. The 1H NMR spectrum showed
the methylene protons at 4.13 while the aromatic protons were observed as a triplet of triplets
at 7.30 a triplet of triplets at 7.42 and a doublet of triplets at 7.89The 13C NMR spectrum
revealed peaks at 28.10 ppm (CH2-SCN), 109.26 ppm (C-S), 118.43 ppm (-CN), 126.73 ppm,
129.34 ppm, 135.42 ppm, 150.10 ppm (C=N) and 150.30 ppm (C=O). The results of an
elemental analysis performed on the compound were within acceptable values if corrected by
adding a 1/8th molecule of water to the molecular formula (MF: C10H7N3O2S • 1/8 H2O).
Table 11. Elemental analysis of 5-(thiocyanomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
Atom
C
H
N

Theory
51.49
3.03
18.02

Found
50.90
2.96
17.50
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Corrected
51.00
3.10
17.84

Halogenation and Subsequent Transformation of Sydnones to 1,3,4-Oxadiazol-2(3H)-ones
The first part of this objective was the use of ICl in DCM in an attempt to fully chlorinate
sydnones. As mentioned previously, Nashashibi received a mixture of two products (the 4-Cl
(major) and 4-I sydnones) when a sydnone was reacted with ICl in DCM as opposed to the use of
“neat” ICl in AcOH, which resulted in only the 4-I sydnone. In the present work, Nashashibi’s
method (Scheme 23) was further optimized by changing the reaction concentration of ICl in an
attempt to maximize the yield of the 4-chloro-3-phenylsydnone and reduce the yield of the 4iodo product in the reaction mixture. TLC analysis during the reaction allowed for the time
parameter to be reduced significantly (Table 12). The sydnones subjected to chlorination were
selected based on two criteria: 1) they must be readily available in the Turnbull lab. and 2) their
4-Cl analogs must have been fully characterized in the literature. Initial optimization experiments
involved the reaction of 3-phenylsydnone with ICl in DCM while the reaction time and ICl
molar equivalents were modified (Scheme 40).
Scheme 40: Optimization of synthesis of 4-chloro-3-phenylsydnone from 3-phenylsydnone with
ICl in DCM
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Table 12. Parameter modifications and relative product compositions (by TLC)
[ICl]

Reaction Time (h)

Estimated Composition (%)

1.1

0.5

4-Cl: ~60; 4-I: ~35; 4-H: ~5

1.1

6

4-Cl: ~60; 4-I: ~35; 4-H: ~5

1.5

0.5

4-Cl: 70; 4-I: 30

1.5

6

4-Cl: 70; 4-I:30

2

0.5

4-Cl: 80; 4-I: 20

2

6

4-Cl: 80; 4-I: 20

2.5

0.5

4-Cl: 90; 4-I: 10

2.5

6

4-Cl: 90; 4-I: 10

3

0.5

4-Cl: 100

3

6

4-Cl: 100

Following Nashashibi’s reported method, reactions of 3-phenylsydnone (3, R = H) with
1.1 molar equivalents of ICl in DCM for 0.5 h and 6 h were performed. It appeared (TLC
evidence) that each reaction had proceeded to near completion after 0.5 h or 6 h. Entries 1 and 2
of Table 12 reveal that some starting material is present when utilizing 1.1 molar eq. of ICl in
DCM. The concentration was increased in the following syntheses in an attempt to completely
consume the starting material. Thus, the reaction was modified by increasing the molar
equivalents of ICl in DCM from 1.1 eq. to 1.5 eq. in an attempt to consume all of the starting
material and to favor the formation of the 4-chloro congener. The relative amount of the 4-chloro
compound (~70%) increased and the amount of the 4-iodo compound (~30%) decreased as a
result of the increase in the molar excess of ICl in DCM utilized.
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When the concentration of ICl was raised from 1.5 equivalents to 2.0 equivalents the
relative composition of the 4-chloro congener in the mixture improved by an additional ~10%.
The increase from 2.0 to 2.5 molar equivalents of ICl improved the composition in the desired
fashion to a total of ~90% 4-chloro and ~10% 4-iodo-3-phenylsydnone. A final optimization was
conducted using 3.0 molar equivalents of ICl. After 0.5 h the reaction had consumed all the
starting material and provided a single product. The product was compared to 4-chloro-3phenylsydnone by TLC and matched its Rf value exactly. In summary, Table 12 reveals that the
reaction time can be reduced to 30 minutes from 6 hours while increasing the concentration of
ICl to 3 eq. to provide an efficient method for the chlorination of 3-phenylsydnone at the C4
position. After scale up using the optimized procedure, the product was isolated and
characterized via TLC, melting point and its 1H NMR and 13C NMR spectra. By extrapolation, a
general method was thus proposed for the chlorination of sydnones with 3.0 eq. ICl in DCM
(Scheme 41).
Scheme 41: General synthesis of 4-chloro-3-arylsydnones using ICl in DCM

Using the optimized procedure, a full extension was conducted to test the generality of
this reaction across a series of 3-arylsydnones (Scheme 42).
Scheme 42: Reaction of a variety of 3-arylsydnones with the generalized procedure
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Table 13. Corresponding yields and melting points for the products 26a-h, obtained by
chlorination of 25a-h with ICl in DCM
Recrystallized Yield
Products

Lit.

MP (°C)33

Expt. MP (°C)

Yield (%)
(%)

26a

126-127

116.5-117

87

72

26b

107-108

108-109

92.1

71

26c

109-110

111-112

108

71

26d

136-138

138-139

95

81

26e

N/A

138-139

84

46

26f

99-100

101-102

92.4

68

26g

95-96

93-94

92.4

74

26h

126-128

125-127

94

76.4

All of the experimentally obtained melting points match the literature melting points
except for in one case, 26a. The literature melting point could potentially have been misreported
by Badami, therefore, alternative methods of characterization were employed in order to identify
26a. The product was fully characterized by its NMR spectra and was identified as the
chlorinated sydnone 26a. The total yields from this process varied from about 46%-81% after
recrystallization from 80% ethanol, however, most of the compounds were sufficiently pure to be
used in reactions without prior purification.
The second part of this section is dedicated to the synthesis of 5-methyl-3-aryl-1,3,4oxadiazol-2(3H)-ones in one-pot using the chlorinated sydnones 26a-h previously synthesized in
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Scheme 40. Inspiration for this procedure arose from work performed by Yeh et al. in 1994
(Scheme 43).
Scheme 43: Reaction of 4-bromo-3-phenylsydnone with AcOH6

Using the information provided by Yeh et al., as shown in Scheme 41, a general synthetic
route was proposed in an attempt to accomplish the one-pot synthesis of 3-aryl-5-methyloxadiazolinones 27a-h from 4-chloro-3-arylsydnones 26a-h, as shown in Scheme 44.
Scheme 44. Proposed synthesis of 27a-h from 4-chloro-3-arylsydnones 26a-h

Previously reported conditions for the synthesis of 6a from unsubstituted sydnones
(Scheme 20) suggest refluxing at a temperature of 65°C but, in the present work, the temperature
was increased because the previous process used the 4-bromo sydnone 5 as the starting material.
This is of importance because, from our proposed mechanism (Scheme 19), the bromine is
expected to be a better leaving group (than the chlorine in 26a) upon the second attack by the
oxygen of the newly attached acyl group. A chlorine atom is expected to be the leaving group in
the final heterocyclization, therefore the reaction temperature was increased to 80°C in the hope
that this would ensure that the reaction proceeded to completion (Scheme 45). Further, the
solvent used typically is acetic anhydride, which could become expensive if the procedure were
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extended to a specialized anhydride and, accordingly, acetic acid was used as both a diluent and
the acid catalyst for the reaction. Accordingly, this optimization employed 3.0 eq. of acetic
anhydride and used acetic acid as the solvent at 80°C.
Scheme 45. Synthesis of 27a-h from 4-chloro-3-arylsydnones (26a-h) using optimized
conditions

The procedure in Scheme 45 provided the expected target materials 27a-h, without
recrystallization and in moderately high yields. The experimental melting points matched the
literature melting points except for compounds 27f-h, which are undocumented in the literature,
and, therefore, total characterization was performed on the latter. Indeed, all of the products 27ah were characterized by 1H NMR and 13C NMR spectroscopies and by melting point
comparisons with authentic materials (where possible) [Tables 14 and 15]. The observed
experimental melting points for 27b and 27e do not match the literature melting points and this is
likely attributed to a discrepancy in the reporting of the literature melting points. There is no
reason to believe that the products were not isolated on the basis of matching 13C NMR chemical
shifts (see appendix) and since the other group of products correspond with the reported
literature melting points and NMR chemical shifts.
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Table 14. Melting points and yields of 27a-h obtained by reaction of 26a-h with Ac2O in AcOH
Products Literature MP (°C)33 Experimental MP (°C)

Yield (%)

27a

91-92

90-91

78

27b

98-99

121-122

93

27c

128-129

124-125

98

27d

82-83

79-80

97

27e

138-139

168-170

64

27f

-

90-92

77

27g

-

75-76

88

27h

-

64-65
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Table 15. 13C NMR chemical shifts experimentally obtained for the products 27a-h
Identifier

Expt. Chemical Shift (ppm)

27a

12.18, 118.08, 125.91, 129.16, 136.00, 151.09, 153.79

27b

12.19, 119.20, 129.25, 131.26, 135.55, 150.84, 153.99

27c

12.20, 119.00, 119.49, 132.20, 136.05, 150.79, 154.02

27d

12.18, 20.92, 118.15, 133.58, 135.74, 151.16, 153.61

27e

12.21, 26.53, 117.32, 129.67, 134.24, 139.59, 150.71, 154.37, 196.77

27f

12.16, 55.50, 114.50, 120.03, 129.23, 151.28, 153.56, 157.67

27g

12.16, 55.44, 103.68, 110.19, 111.92, 130.01, 137.08, 150.99, 153.69, 160.24

27h

12.31, 14.42, 20.32, 124.30, 126.20, 130.86, 133.71, 133.85, 138.63, 152.75, 153.98
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To summarize this synthetic avenue, 4-chloro-3-arylsydnones were subjected to ring
cleavage by warming with a weak acid (AcOH). The expected intermediates of this process are
the acetate salts of the corresponding chlorocarbonylaryl hydrazine, which then, presumably,
react readily with the available 3 equivalents of acetic anhydride present in the mixture to yield
the oxadiazolinone products (Scheme 46). The main limitation to this process is that extension to
other anhydrides is problematic since using acetic acid with a non-corresponding anhydride (e.g
acetic acid as solvent and propionic anhydride as reagent) will surely lead to mixed anhydrides
and products possessing parts of either the anhydride or the solvent. Future reactions should
consider an alternative solvent such as ethyl acetate and perhaps a non-nucleophilic acid (e.g.
para-toluenesulfonic acid) to allow for the extension of this process to acid halides and other
acid anhydrides.
Scheme 46: Synthesis of 27a-h from 4-chloro-3-arylsydnones 26a-h including proposed
intermediate

80°C, 3 h.
26a-h

27a-h
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Conclusion
The synthesis of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-(3H)-one (6b), reported
previously by Madaram, was optimized successfully by modifying time, temperature and
stochiometric parameters. The impurities present in a crude product mixture of 6b were
identified as 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (11) and 5-(iodomethyl)-3phenyl-1,3,4-oxadiazol-2(3H)-one (12). The sources of 11 and 12 were identified as the
chloroacetyl and iodoacetyl chloride impurities contained within the commercially available
reagent, bromoacetyl chloride. Halogens attached at the C4-positon of the sydnone ring (prior to
acid cleavage of the ring) and the various counterions associated with the hydrazine salts were
modified to improve the overall purity and yield of 6b. The optimal hydrazine salt and haloacetyl
halide reagent combination with the greatest overall success was identified as bromocarbonylphenylhydrazine hydrochloride salt 10b paired with bromoacetyl chloride. These results were
unexpected because bromoacetyl chloride is relatively impure compared to bromoacetyl
bromide, but provided 6b in the greatest yield with the highest purity. The total impurities in a
sample of 6b were reduced to no more than 2%. Recrystallization of 6b resulted in poor recovery
yields, accompanied with minimal change in the overall product distribution. Accordingly, in
general, the recrystallization optimization was not pursued, but ideally could be modified by
changing either the solvent or the method of recrystallization.
The procedure developed for 6b was used as the foundation for the synthesis of 5(trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (13); the sole modification being the
acetyl halide utilized, trichloroacetyl chloride. Trichloroacetyl chloride is an example of a
bulkier, electron withdrawing substrate that could potentially hinder the heterocyclization
process. The temperature of the system was increased to 70°C in order to allow complete
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heterocyclization. The product 13 was identified by GC/MS, IR, 1H and 13C NMR
spectroscopies, melting point and elemental analysis. No further reactions were performed
involving 13, however, it would be beneficial to determine the relative lability of the
trichloromethyl functional group in an attempt to synthesize diverse analogs thereof via
nucleophilic substitution.
The improved availability and purity of 6b permitted further exploration into its chemical
reactivity. The latter was probed chemically by reacting controlled quantities of 6b with a variety
of nucleophilic and electrophilic substrates. The results of the reactions were examined by both
TLC and GC/MS in order to identify the product(s), whether or not a reaction had taken place,
and whether or not the process was selective or non-selective towards the targeted active site.
Klaasen’s method for the nitration of 1,3,4-oxadiazol-2(3H)-ones was applied to the 5bromomethyl oxadiazolinone 6b in an attempt to isolate the para-nitro species 18, however, with
minimal success. Compound 18 was identified in a mixture with the ortho-nitro compound 19
and occasionally the dinitro species 20, depending on the conditions. Time, temperature and
duration of KNO3 addition were modified to maximize the formation of 18. Complete conversion
of the starting material to 18 utilizing the current conditions was not achieved; therefore,
recrystallization was attempted on the product mixture. Recrystallization of the crude material
resulted in a similar product distribution of 18 and 19 by GC/MS and thus, was no longer
pursued. Since 18 could not be isolated solely from a crude product mixture generated using
Klaasen’s protocol for mononitration of 6a, an alternative avenue was pursued. The formation of
the dinitro species 20 appeared to be favorable (by GC/MS), especially in the experiments that
added KNO3 over 15 minutes, and accordingly a synthetic avenue was explored involving 3.3
molar eq. of KNO3 and the starting material 6b. This reaction was successful and provided 5-
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(bromomethyl)-3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one (20) in high yield and purity.
The procedure was also conducted on the chloromethyl congener 11 to provide 5-(chloromethyl)3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one (21) in high yield and purity without
recrystallization. The products were undocumented and, accordingly, were fully characterized
utilizing GC/MS, IR, 1H and 13C NMR spectroscopies, melting point and elemental analysis. The
proposed route to the dinitro species eliminates the possibility of post-functionalization of 18 to a
single primary amine, but does provide a route to otherwise unknown 1,3,4-oxadiazol-2(3H)ones with potential for alternative transformations. Unfortunately, the main goal for the synthesis
of an aminomethyl species from the para-nitro compound 18 was not realized largely due to the
inability to isolate 18 from the crude mixtures.
Several reactions were explored using “hard” or “soft” nucleophiles in an attempt to
selectively displace the halogen atom and to reduce the potential for a nucleophilic attack at the
lactone-like carbonyl of the oxadiazolinone ring. The first reagent employed was sodium azide
along with 6b to form product 22. Optimizations involved modifying the molar equivalents of
sodium azide and increasing the reaction temperature. The optimized synthesis provided 22 in
moderately high yield and purity. The optimized procedure was applied to 11 using 2 molar
equivalents of sodium azide and a reaction time of 4 h. The product 22 was previously
undocumented in the literature and, accordingly, was fully characterized by GC/MS, IR, 1H and
13

C NMR spectroscopies, melting point and elemental analysis. The premise behind this

experiment was to obtain a substituent attached at the C5-position of the oxadiazolinone ring that
could be modified in one fashion or another into a primary amine. The ideal functionalization
can be achieved by utilizing Staudinger’s reduction of azides to form primary amines. Many
attempts were carried out with 22 and triphenylphosphine in THF, resulting in highly impure
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product mixtures comprised of seven or more components. Different solvents were employed
along with step-wise modifications to Staudinger’s reduction procedure in an attempt to
minimize the impurities, unfortunately, with no success. A more complete study should be
conducted in the future to better understand the Staudinger reduction of 22 with
triphenylphosphine and then water, in-situ.
The other “soft” nucleophilic reagent studied was ammonium thiocyanate with 6b to
generate compound 24. It was recognized that since the nucleophile is ambident, either the
isocyanate or isothiocyanate species could be formed. The molar equivalents of NH4SCN and the
reaction time were modified in attempt to optimize the procedure. The optimized procedure
provided a single spot by TLC that differed from the starting material, indicating that the reaction
had proceeded and is of a non-competitive nature. The product was obtained in high yield and
purity as ascertained by the GC/MS results. To identify the compound (specifically the
substituent attached to the methylene carbon at the C5-position of the oxadiazolinone ring), IR,
1

H and 13C NMR, melting point and elemental analysis were conducted. It was confirmed that

the substituent was the thiocyanate based on the IR absorption and 13C chemical shift associated
with the nitrile functional group of the thiocyanate. Future experiments with 24 could involve the
use of different solvents, such as a non-polar solvent, to observe if the formation of the
isothiocyanate adduct can be favored. Also, post-modification of the thiocyanate functional
group to form a thiol could be accomplished with 24 and a mineral acid, but this was not pursued
in this study due to time limitations.
The final group of experiments in the present study was based on the past research
conducted by Imad Nashashibi in the Turnbull lab. wherein he showed that treatment of an
unsubstituted sydnone with ICl in DCM gave a mixture of a 4-chloro- and a 4-iodo- sydnone.
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This work was reinvestigated in the present work with the expectation that modification of the
reaction conditions would lead to selective formation of the 4-chloro sydnone. The initial results
with 3-phenylsydnone, utilizing 1.1 molar eq. of ICl in DCM, provided a 60:40 mixture of 4chloro-3-phenylsydnone and 4-iodo-3-phenylsydnone. A reaction optimization study was
conducted in an attempt to completely convert the starting material to the chlorinated congener.
The modified parameters considered were the molar equivalents of ICl, reaction duration and the
solution with which the reaction mixture was quenched. The optimal conditions were identified
as 3.3 molar eq. of ICl in DCM for 0.5 h., providing 4-chloro-3-phenylsydnone in high yield and
purity. An effective modification was to quench with 2% Na2SO3 solution to remove free
halogenated species, such as iodine. In order to confirm the identity of the 4-chloro product, the
colorless crystals obtained after recrystallisation were compared by TLC, m.p., 1H NMR, 13C
NMR to the literature values reported for 4-chloro-3-phenylsydnone. The procedure was
generalized to a variety of 3-arylsydnones 25a-h to form the corresponding 4-chloro-3arylsydnones 26a-h in high yields and purities after recrystallization. The identities of the
products 26a-h were confirmed by their melting points and 1H NMR and 13C NMR spectra.
Lastly, a route to the synthesis of 5-methyl-3-aryl-1,3,4-oxadiazol-2(3H)-ones 27a-h
from 4-chloro sydnones, using acetic acid as solvent instead of acetic anhydride, was proposed
and proven successful. The route was optimized using 4-chloro-3-phenylsydnone (26a), which
was readily available in the laboratory, and the amount of acetic anhydride was reduced to 1.5
molar eq. while using acetic acid as solvent. A high yield of the corresponding oxadiazolinone
27a was obtained, however, a limitation to the process was that extension to propionic anhydride
in acetic acid, gave a complex product mixture. Accordingly, in order to avoid complex product
mixtures, the acid and anhydride used must possess the same functional groups otherwise
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products resulting from mixed anhydrides will be apparent. The procedure was extended to other
4-chloro sydnones 26b-h utilizing the optimized parameters, viz. acetic acid as the solvent and
acetic anhydride used in 0.5 molar excess. The expected products 27b-h were obtained in high
yields and purity. The identities of the products 27a-h were confirmed by comparing their
melting points, 1H NMR and 13C NMR spectra to the literature data. The proposed procedure
efficiently generates 5-methyl-3-aryl-1,3,4-oxadiazol-2(3H)-ones from 4-chloro-3-arylsydnones
while reducing substantially the amount of acetic anhydride used.
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Experimental
Synthesis of 3-phenylsydnone
3-phenylsydnone was obtained in 71% yield in two steps from commercially available Nphenylglycine.
Nitrosation of N-phenylglycine to yield N-nitroso-N-phenylglycine (1)1
N-Phenylglycine (15.00 g, 99.24 mmol) was suspended in distilled water (160 mL) and
was stirred in an ice bath at 0°C. A solution of sodium nitrite (7.54 g, 112.58 mmol) in distilled
water (150 mL) was added dropwise over 0.5 h. The reaction mixture stirred for an additional
hour in the ice bath, at which point activated carbon (~500 mg) was added. The reaction mixture
was stirred vigorously for 10 minutes and was vacuum filtered. Concentrated HCl (30 mL) was
added dropwise to the filtrate while stirring in a cooling bath. A tan precipitate formed, which
was vacuum filtered and dried overnight to yield N-nitroso-N-phenylglycine (1) as a light tan
powder (13.80 g, 84%), m.p. 100-101°C (lit1 m.p. 103-104°C).
Cyclisation of N-nitroso-N-phenylglycine to N-phenylsydnone (3, R=H)1
N-nitroso-N-phenylglycine (13.80 g, 83.10 mmol) in acetic anhydride (70 mL) was
refluxed in an oil bath at 100°C for 2 h. with stirring. The red solution was cooled to room
temperature and was quenched in distilled water (200 mL). The quenched mixture was cooled to
maximize the formation of the tan precipitate. The precipitate was collected via vacuum filtration
and was dried overnight to yield the sydnone 3, R=H as a light tan solid (9.84 g, 73%), m.p. 131132°C (lit.1 m.p. 134°C)
Bromination of 3-phenylsydnone to form 4-bromo-3-phenylsydnone (5)3
To 3-phenylsydnone (3.47 g, 21.37 mmol) in 95% ethanol (40 mL) was added saturated
sodium bicarbonate solution (5.40 g, 64.10 mmol) in DI H2O (~140 mL) with stirring in an ice
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bath. A separate solution of Br2 (3.28 mL, 64.10 mmol) in ethanol (~80 mL) was added dropwise
over a period of 40 minutes. The reaction mixture was stirred for an additional 30 minutes and
was quenched in DI H2O (~175 mL). A creamy orange precipitate formed, which was collected
and dried via vacuum filtration. The product 5 was obtained as a light orange-tan powder (4.84 g,
94%), m.p. 137-138°C (lit.2 m.p. 139°C).
Preparation of N-phenyl-N-bromocarbonylhydrazine hydrochloride (10b)6
To 4-bromo-3-phenylsydnone (1.10 g, 4.56 mmol) stirred in ethyl acetate (~40 mL) was
added concentrated HCl (1.75 mL). The reaction mixture was stirred under reflux at 60°C for 30
minutes then cooled to room temperature and quenched in ice-cold ethyl acetate (~40 mL). A
white precipitate was observed after cooling in an ice bath. The product 10b was collected and
then dried via vacuum filtration to yield a white powder (0.73 g, 63%), m.p. 160-161°C (lit.6 m.p.
154°C) IR: 1747.37, 2587.96, 2924.12, 3431.51 cm-1
Synthesis of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b)
To the bromocarbonylhydrazine hydrochloride 10b (1.25 g, 4.98 mmol) in 1,2dimethoxyethane (50 mL) was added bromoacetyl chloride (441 µL, 5.22 mmol) with stirring.
The reaction mixture was refluxed at 55°C for 1 hour then cooled to room temperature and
quenched in DI H2O (~120 mL). The 1,2-DME reduced in volume overnight to yield a light tan
precipitate, which was collected via vacuum filtration. The product was collected and dried via
vacuum filtration to yield a tan powder (1.00 g, 79%) identified as 6b, m.p. 80-81°C, IR:
1733.45, 1778.51, 2918.16, 2981.30, 3041.76 cm-1; 1H NMR: 4.29 (2H, s), 7.29 (1H, d), 7.46
(2H, t), 7.85 δ (2H, d); 13C NMR: 17.64, 118.33, 126.53, 129.28, 135.58, 152.00 ppm.
Synthesis of 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (11)
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To the bromocarbonylhydrazine hydrochloride 10b (0.16 g, 0.78 mmol) in 1,2dimethoxyethane (12 mL) was added chloroacetyl chloride (75µL, 0.93 mmol) with stirring. The
reaction mixture was refluxed at 65°C for 1 hour then cooled to room temperature and quenched
in DI H2O (~30 mL). The 1,2-DME was reduced in volume overnight to yield a white
precipitate, which was collected via vacuum filtration. The product was collected and dried via
vacuum filtration to yield a white crystalline powder (0.100 g, 70%) identified as 11, m.p. 8485.5°C, IR: 1781.64, 1907.55, 2977.34, 3033.01, 3067.69 cm-1, 1H NMR: 4.47 (2H, s), 7.30 (1H,
d), 7.46 (2H, t), 7.83 (2H, d). 13C NMR: 34.00, 118.32, 126.54, 129.29, 135.56, 150.26, 151.81
ppm.
Synthesis of 5-(trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (13)
To the bromocarbonylhydrazine hydrochloride 10b (0.20 g, 0.80 mmol) in 1,2dimethoxyethane (9 ml) was added trichloroacetyl chloride (135 µL, 1.19 mmol) with stirring.
The reaction mixture was refluxed at 65°C for 1.5 hours then cooled to room temperature and
quenched in DI H2O (~30 mL). The 1,2-DME was reduced in volume overnight to yield a yellow
precipitate, which was collected via vacuum filtration. The product was collected and dried via
vacuum filtration to yield a white powder (0.20 g, 88%) identified as 13, m.p.(crude) 104-107°C.
The product was recrystallized from absolute ethanol (~8 mL) to afford sharp, pale-yellow
crystals (0.13 g, 56%), m.p. 111-111.5°C, IR: 1330.65, 1596.41, 1793.35, 1880.85 cm-1; 1H
NMR: 7.31, 7.33, 7.36, 7.46, 7.48, 7.51, 7.84, 7.87 δ; 13C NMR: 82.99, 118.72, 127.16, 129.42,
135.18, 149.37, 151.41 ppm.
Synthesis of 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (22)
To 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b) [0.25 g, 0.99 mmol] in
ethanol (27 mL) was added sodium azide (0.07 g, 1.10 mmol) slowly with stirring. The reaction
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mixture was stirred under reflux at ~78°C for 2 hours whereupon the reaction mixture was
cooled to room temperature then quenched in cold DI H2O (50 mL). The ethanol was reduced in
volume overnight in the fume hood to yield a white precipitate. The product was collected and
dried via vacuum filtration to yield a white powder (0.17 g, 80%) identified as 22, m.p. 6464.5°C, IR: 956.12, 1364.23, 1376.10, 1785.57, 2113.44, 2194.18 cm-1; 1H NMR: 4.33 (2H, s),
7.31 (1H, d), 7.46 (2H, t), 7.83 δ (2H, d); 13C NMR: 30.90, 45.20, 118.33, 126.51, 129.29,
135.60, 151.43 ppm.
Synthesis of 5-(thiocyanomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (24)
To 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b) [0.25 g, 0.99 mmol] in
anhydrous acetonitrile (~20 mL) was added ammonium thiocyanate (0.12 g, 1.74 mmol) in
acetonitrile with stirring. The reaction mixture was stirred for 10 hours at room temperature and
then was quenched in DI H2O (~40 mL). A yellow precipitate formed after the volume of
acetonitrile reduced completely overnight. The product was collected and dried via vacuum
filtration to yield a yellow powder (0.21 g, 91%) identified as 24, m.p. 113-114.5°C. The product
was recrystallized from warm 95% ethanol (~15mL) to yield yellow crystals upon cooling,
which were collected via vacuum filtration (0.15 g, 70%), m.p. 115.5-116.5°C, IR: 1781.51,
2165.53 cm-1; 1H NMR: 4.13 (2H, s), 7.30 (1H, d), 7.42 (2H, t), 7.89 δ (2H, d); 13C NMR: 28.10,
109.26, 118.43, 126.73, 129.34, 135.42, 150.10, 150.30 ppm.
Synthesis of 5-(bromomethyl)-3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one (20)
5-(Bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (6b) [0.09 g, 0.34 mmol] was
stirred in H2SO4 (2 mL) using an ice/salt bath to maintain a temperature of -10°C. Potassium
nitrate (0.12 g, 1.11 mmol) was added slowly to the reaction mixture over a period of ~15
minutes. The reaction mixture stirred at -10°C for a further 1.5 hours and was quenched in ice/DI
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H2O (~25 mL). The quenched mixture was extracted with DCM (3 x 5 mL) and the combined
DCM layers were washed with saturated aqueous sodium bicarbonate solution (~50 mL). The
DCM layer was separated, dried with MgSO4, gravity filtered and evaporated in vacuo to yield
the product 20 as an orange solid (0.10 g, 86.2%), m.p.122-123°C, IR: 1343.67, 1541.11,
1608.03, 1800.34, 3087.40 cm-1; 1H NMR: 4.30 (2H, s), 8.07 (1H, d), 8.59 (1H, d), 8.82 δ (1H,
s); 13C NMR: 16.97, 121.49, 126.12, 127.99, 132.22, 142.29, 146.16, 149.61, 154.35 ppm.
Synthesis of 5-(chloromethyl)-3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one (21)
5-(Chloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (11) [0.08 g, 0.36 mmol] was
stirred in H2SO4 (2 ml) using an ice/salt bath to maintain a temperature of -10°C. Potassium
nitrate (0.11 g, 1.07 mmol) was added slowly to the reaction mixture over a period of ~15
minutes. The reaction mixture was stirred at -10°C for a further 1.5 hours and was quenched in
ice/DI H2O (~25 mL). The quenched mixture was extracted with DCM (3 x 5 mL) and the
combined DCM layers were washed with saturated sodium bicarbonate solution (~50 mL). The
DCM layer was separated, dried with MgSO4, gravity filtered and evaporated in vacuo to yield
the product 21 as a yellow solid (0.10 g, 97%), m.p. 105-107°C, IR: 1347.07, 1545.28, 1608.62,
1634.77, 1801.74, 3088.62 cm-1; 1H NMR: 4.50 (2H, s), 8.05 (1H, d), 8.59 (1H, d), 8.87 δ (1H,
s); 13C NMR: 33.64, 121.50, 126.16, 128.01, 132.21, 142.30, 146.20, 149.61, 154.10 ppm.
Synthesis of 4-chloro-3-phenylsydnone (26a)
To a stirred solution of 3-phenylsydnone (1.01 g, 6.24 mmol) in anhydrous DCM (~25
mL) was added anhydrous sodium acetate (1.54 g, 18.73 mmol). Iodine monochloride (18.80
mL, 18.73 mmol) was added slowly to the mixture and the reaction mixture was stirred under N2
(g) at room temperature for a further 2 hours whereupon it was quenched in 2% aqueous sodium
sulfite (6.0 g, in 250 mL DI H2O). The quenched mixture was extracted with DCM (3 x 15mL)
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and the combined DCM layers were separated and washed with saturated sodium bicarbonate
solution (60 mL). The DCM layer was separated, dried with MgSO4, gravity filtered and
evaporated in vacuo to yield the product 26a as light tan spherulites (1.11 g, 90%) identical to an
authentic sample (m.p. 116.5-117°C, lit. mp. 126-127°Cref, 1H NMR: 7.66 (2H, d), 7.72 (2H, t),
7.75 δ (1H, d) 13C NMR: 121.33, 124.40, 130.17, 130.31, 132.50, 132.78 ppm.
Synthesis of 4-chloro-3-(4-chlorophenyl)sydnone (26b)
To a stirred solution of 3-(4-chlorophenyl)sydnone (25b) [0.20 g, 1.02 mmol] in
anhydrous DCM (~10 mL) was added anhydrous sodium acetate (0.25 g, 3.07 mmol). Iodine
monochloride (3.10 mL, 3.07 mmol) was added slowly to the mixture and the reaction mixture
stirred under N2 (g) at room temperature for 30 minutes whereupon it was quenched in 2%
sodium sulfite (2.0 g, in 60 mL DI H2O). The quenched mixture was extracted with DCM (3 x
15mL) and the combined DCM layers were separated and washed with saturated sodium
bicarbonate solution (60 mL). The DCM layer was separated, dried with MgSO4, gravity filtered
and evaporated in vacuo to yield the product (26b) as light yellow sphereulites (0.22 g, 92.1%).
Recrystallization of the product from 80% ethanol (~8 mL) provided 2 crops of sharp yelloworange crystallites (0.17 g, 71%), m.p. 108-109°C, lit. m.p. 108-109°C33, 1H NMR: 7.635 (2H,
d), 7.64 δ (2H, d).
Synthesis of 4-chloro-3-(4-bromophenyl)sydnone (26c)
To a stirred solution of 3-(4-bromophenyl)sydnone (25c) [0.20 g, 0.84 mmol] in
anhydrous DCM (~10 mL) was added anhydrous sodium acetate (0.21 g, 2.53 mmol). Iodine
monochloride (2.60 ml, 2.53 mmol) was added slowly and the reaction mixture was stirred under
N2 (g) at room temperature for 30 minutes whereupon it was quenched in 2% sodium sulfite (2.0
g, in 60 mL DI H2O). The quenched mixture was extracted with DCM (3 x 15mL) and the
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combined DCM layers were separated and washed with saturated sodium bicarbonate solution
(60 mL). The DCM layer was separated, dried with MgSO4, gravity filtered and evaporated in
vacuo to yield the product as light tan spherulites (0.25 g, 108%). Recrystallization from 80%
ethanol (~8 ml) provided 26c as 3 crops of sharp tan crystallites (0.16 g, 71%), m.p. 111-112°C,
lit. m.p. 110-111°C16, 1H NMR: 7.56 (2H, d), 7.83 δ (2H, d).
Synthesis of 4-chloro-3-(4-methylphenyl)sydnone (26d)
To a stirred solution of 3-(4-methylphenyl)sydnone (25d) [0.20 g, 1.14 mmol] in
anhydrous DCM (~10 ml) was added anhydrous sodium acetate (0.28 g, 3.43 mmol). Iodine
monochloride (3.5 mL, 3.43 mmol) was added slowly to the mixture and the reaction mixture
stirred under N2 (g) at room temperature for 30 minutes whereupon it was quenched in 2%
sodium sulfite (2.0 g, in 60 mL DI H2O). The quenched mixture was extracted with DCM (3 x
15mL) and the combined DCM layers were separated and washed with saturated sodium
bicarbonate solution (60 mL). The DCM layer was separated, dried with MgSO4, gravity filtered
and evaporated in vacuo to yield the product (26d) as a tan powder (0.22 g, 90%).
Recrystallization of the product from 80% ethanol (~8 mL) provided 2 crops of sharp darkbrown crystals (0.19 g, 81%), m.p. 138.5-139°C, lit. m.p. 136-138°C33, 1H NMR: 2.52 (3H, s),
7.46 (2H, d), 7.54 (2H, d) δ.
Synthesis of 4-chloro-3-(4-acetylphenyl)sydnone (26e)
To a solution of 3-(4-acetylphenyl)sydnone (25e) [0.50 g, 2.45 mmol] in anhydrous DCM
(~20 mL) was added anhydrous sodium acetate (0.60 g, 7.35 mmol). Iodine monochloride (7.40
mL, 7.35 mmol) was added slowly to the mixture and the reaction mixture stirred under N2 (g) at
room temperature for 30 minutes whereupon it was quenched in 2% sodium sulfite (6.0 g, in 150
mL DI H2O). The quenched mixture was extracted with DCM (3 x 15mL) and the combined
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DCM layers were separated and washed with saturated sodium bicarbonate solution (120 mL).
The DCM layer was separated, dried with MgSO4, gravity filtered and evaporated in vacuo to
yield the product (26e) as light orange crystallites (0.27 g, 46%), m.p. 138-139, lit. m.p. 139140°C33 1H NMR: 2.73 (3H, s), 7.82 (2H, d), 8.25 δ (2H, d); 13C NMR: 26.87, 98.52, 121.62,
124.88, 125.62, 129.93, 130.02, 130.25, 135.97, 140.11, 140.22, 163.71, 196.08 ppm.
Synthesis of 4-chloro-3-(4-methoxyphenyl)sydnone (26f)
To a stirred solution of 3-(4-methoxyphenyl)sydnone (25f) [0.20 g, 1.05 mmol] in
anhydrous DCM (~10 mL) was added anhydrous sodium acetate (0.26 g, 3.15 mmol). Iodine
monochloride (3.20 mL, 3.15 mmol) was added slowly to the mixture and the reaction mixture
stirred under N2 (g) at room temperature for 30 minutes whereupon it was quenched in 2%
sodium sulfite (2.0 g, in 60 mL DI H2O). The quenched mixture was extracted with DCM (3 x
15mL) and the combined layers were separated and washed with saturated sodium bicarbonate
solution (60 mL). The DCM layer was separated, dried with MgSO4, gravity filtered and
evaporated in vacuo to yield the product (26f) as a brown solid (0.23 g, 92.4%). Recrystallization
of the product from 80% ethanol (~8 mL) provided 2 crops of sharp yellow-orange crystallites
(0.16 g, 68%), m.p. 101-102°C, lit. m.p. 100-101°C33, 1H NMR: 2.93 (3H, s), 7.13 (2H, d), 7.58 δ
(2H, d).
Synthesis of 4-chloro-3-(3-methoxyphenyl)sydnone (26g)
To a solution of 3-(3-methoxyphenyl)sydnone (25g) [0.20 g, 1.05 mmol] in anhydrous
DCM (~10 mL) was added anhydrous sodium acetate (0.26 g, 3.14 mmol. Iodine monochloride
(3.20 mL, 3.14 mmol) was added slowly to the mixture and the reaction mixture stirred under N2
(g) at room temperature for 30 minutes whereupon it was quenched in 2% sodium sulfite (2.0 g,
in 60 mL DI H2O). The quenched mixture was extracted with DCM (3 x 15mL) and the
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combined DCM layers were separated and washed with saturated sodium bicarbonate solution
(60 mL). The DCM layer was separated, dried with MgSO4, gravity filtered and evaporated in
vacuo to yield the product (26g) as orange spherulites (0.22 g, 92.4%). Recrystallization of the
product from 80% ethanol (~8 mL) provided 2 crops of bright orange crystallites (0.17 g, 74%),
m.p. 93-94°C, lit. m.p. 95-96°C33 1H NMR: 7.15 (2H, d), 7.23, (2H, t), 7.57 δ (1H, d).
Synthesis of 4-chloro-3-(3,4-dimethylphenyl)sydnone (26h)
To a solution of 3-(3,4-dimethylphenyl)sydnone (25h) (0.25 g, 1.32 mmol) in anhydrous
DCM (~10 mL) was added anhydrous sodium acetate (0.33 g, 3.97 mmol). Iodine monochloride
(4.00 mL, 3.97 mmol) was added slowly to the mixture and the reaction mixture stirred under N2
(g) at room temperature for 30 minutes whereupon it was quenched in 2% sodium sulfite (2.0 g,
in 60 mL DI H2O). The quenched mixture was extracted with DCM (3 x 15mL) and the
combined DCM layer was separated and washed with saturated sodium bicarbonate solution (60
mL). The DCM layer was separated, dried with MgSO4, gravity filtered and evaporated in vacuo
to yield the product (26h) as translucent spherulites (0.23 g, 76%), m.p. 64-65°C, 1H NMR: 2.04
(3H, s), 2.35 (3H, s), 7.10 (1H, s), 7.29 (1H, d), 7.40 δ (1H, d); 13C NMR: 13.95, 20.23, 123.60,
126.90, 132.12, 132.74, 133.85, 139.70, 163.77 ppm.
Synthesis of 5-(methyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one (27a)
4-Chloro-3-phenylsydnone (0.20 g, 1.03 mmol) stirred in acetic acid (~1.3 mL) and
acetic anhydride (293 µL, 3.10 mmol) was refluxed at 75°C for 4 hours. The reaction mixture
was cooled and quenched in DI H2O (~25 mL). The quenched mixture was warmed to 50°C for
~10 minutes while stirring. The precipitate became semi-miscible when warmed and precipitated
upon cooling in an ice bath affording a white precipitate. The precipitate was collected via
vacuum filtration and the solid was rinsed with cold DI H2O (~10 mL) to yield the product (27a)
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as a pale yellow-tan solid was obtained (0.14 g,.72%), m.p. 89-90°C, lit. m.p. 91-92°C31 1H
NMR: 2.34 (3H, s), 7.21 (1H, d), 7.45 (2H, d), 8.74 δ (2H, d), 13C NMR: 12.16, 17.70, 118.06,
118.28, 125.89, 126.49, 129.16, 129.26, 136.00, 151.08, 153.80 ppm.
Synthesis of 5-(methyl)-3-(4-chlorophenyl)-1,3,4-oxadiazol-2(3H)-one (27b)
4-Chloro-3-(4-chlorophenyl)sydnone (26b) [0.11 g, 0.46 mmol] stirred in acetic acid (800
µL) and acetic anhydride (132 µL, 1.39 mmol) was refluxed at 80°C for 4 hours and was
quenched in DI H2O (~15 mL). The quenched mixture was warmed to 50°C for ~10 minutes
while stirring. The precipitate became semi-miscible when warmed and precipitated upon
cooling in an ice bath affording a white precipitate. The precipitate was collected via vacuum
filtration and the solid was rinsed with cold DI H2O (~10mL) to yield the product (27b) as a tan
solid (0.09 g, 93%), m.p. 112-115°C. Recrystallization of the product in hot 95% ethanol (~ 5
mL) afforded 2 crops of translucent tan crystals (0.09 g, 88%), m.p. 121-122°C, lit. m.p. 9899°C33 1H NMR: 2.36, 7.39 (2H, d), 7.79 δ (2H, d), 13C NMR: 12.19, 119.20, 129.25, 131.26,
134.55, 150.84, 153.99 ppm.
Synthesis of 5-(methyl)-3-(4-bromophenyl)-1,3,4-oxadiazol-2(3H)-one (27c)
4-Chloro-3-(4-bromophenyl)sydnone (26c) [0.10 g, 0.37 mmol] stirred in acetic acid (700
µL) and acetic anhydride (104 µL, 1.10 mmol) was refluxed at 80°C for 4 hours and was
quenched in DI H2O (~15 mL). The quenched mixture was warmed to 50°C for ~10 minutes
while stirring. The precipitate became semi-miscible when warmed and precipitated upon
cooling in an ice bath, affording a white precipitate. The precipitate was collected via vacuum
filtration and the solid was rinsed with cold DI H2O (~10mL). A tan solid remained (0.09 g, 0.36
mmol) Percent yield: 99% (crude), m.p. 119-122°C. Recrystallization of the product in hot 95%
ethanol (~ 3 mL) afforded 2 crops of translucent tan crystals (0.09 g, 98%), m.p. 124-125°C, lit.
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m.p. 128-129°C33 1H NMR: 2.36 (3H, s), 7.54 (2H, d), 7.74 δ (2H, d); 13C NMR: 12.20, 119.00,
119.49, 132.20, 135.05, 150.79, 154.02 ppm.
Synthesis of 5-(methyl)-3-(4-methylphenyl)-1,3,4-oxadiazol-2(3H)-one (27d)
4-Chloro-3-(4-methylphenyl)sydnone (26d) [0.11 g, 0.53 mmol] stirred in acetic acid
(750 µL) and acetic anhydride (150 µL, 1.58 mmol) was refluxed at 80°C for 4 hours and was
then quenched in DI H2O (~15 mL). The quenched mixture was warmed to 50°C for ~10 minutes
while stirring. The precipitate became semi-miscible when warmed and precipitated upon
cooling in an ice bath, affording a white precipitate. The precipitate was collected via vacuum
filtration and the solid was rinsed with cold DI H2O (~10 mL) to yield the product (27d) as a
pale-yellow powder (0.10 g, 100%), m.p. 75-76°C. Recrystallization of the product in hot 95%
ethanol (~ 5 mL) afforded 2 crops of sharp colorless crystals (0.08 g, 81%), m.p. 79-80°C, lit.
m.p. 82-83°C33 1H NMR: 2.35 (3H, s), 2.36 (3H, s), 7.22 (2H, d), 7.69 δ (2H, d), 13C NMR:
12.18, 20.92, 118.15, 133.58, 135.74, 151.16, 153.61 ppm.
Synthesis of 5-(methyl)-3-(4-acetylphenyl)-1,3,4-oxadiazol-2(3H)-one (27e)
4-Chloro-3-(4-acetylphenyl)sydnone (26e) [0.11 g, 0.45 mmol] stirred in acetic acid (800
µL) and acetic anhydride (127.5 µL, 1.35 mmol) was refluxed at 80°C for 4 hours and was
quenched in DI H2O (~15 mL). The quenched mixture was warmed to 50°C for ~10 minutes
while stirring. The precipitate became semi-miscible when warmed and precipitated upon
cooling in an ice bath affording a yellow-orange precipitate. The precipitate was collected via
vacuum filtration and the solid was rinsed with cold DI H2O (~10 mL) to yield 27e as a yellow
solid (0.09 g, 92%), m.p. 168-170°C, lit. m.p. 138-139°C33 1H NMR: 2.35 (3H, s), 3.82 (3H, s),
6.95 (2H, d), 7.70 δ (2H, d); 13C NMR: 12.21, 26.53, 117.32, 129.67, 134.24, 139.59, 150.71,
154.37, 196.77 ppm.
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Synthesis of 5-(methyl)-3-(4-methoxyphenyl)-1,3,4-oxadiazol-2(3H)-one (27f)
4-Chloro-3-(4-methoxyphenyl)sydnone (26f) [0.12 g, 0.53 mmol] stirred in acetic acid
(750 µL) and acetic anhydride (150 µL, 1.59 mmol) was refluxed at 80°C for 4 hours and then
quenched in DI H2O (~15 mL). The quenched mixture was warmed to 50°C for ~10 minutes
while stirring. The precipitate became semi-miscible when warmed and precipitated upon
cooling in an ice bath affording a tan precipitate. The precipitate was collected via vacuum
filtration and the solid was rinsed with cold DI H2O (~10 mL) to yield 27f as a brown solid
(0.095 g, 88%), m.p. 90-92°C, 1H NMR: 2.38, 2.62, 7.96, 8.04 δ, 13C NMR: 12.16, 55.50,
114.50, 120.03, 129.23, 151.28, 153.56, 157.67 ppm.
Synthesis of 5-(methyl)-3-(3-methoxyphenyl)-1,3,4-oxadiazol-2(3H)-one (27g)
4-Chloro-3-(2-methoxyphenyl)sydnone (26g) [0.10 g, 0.44 mmol] stirred in acetic acid
(700 µL) and acetic anhydride (126 µL, 1.3331 mmol) was refluxed at 80°C for 4 hours and then
quenched in DI H2O (~15 mL). The quenched mixture was warmed to 50°C for ~10 minutes
while stirring. The precipitate became semi-miscible when warmed and precipitated upon
cooling in an ice bath affording a orange-tan precipitate. The precipitate was collected via
vacuum filtration and the solid was rinsed with cold DI H2O (~10 mL) to yield 27g as a tan solid
(0.81 g, 88%), m.p. 75-76°C, 1H NMR: 2.35 (3H, s), 3.84 (3H, s), 6.79 (1H, s), 7.32 (1H, d), 7.43
(1H, t) 7.59 (1H, d) δ; 13C NMR: 12.16, 55.44, 103.68, 110.19, 111.92, 130.01, 137.08, 150.99,
153.69, 160.24 ppm.
Synthesis of 5-(methyl)-3-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2(3H)-one (27h)
4-chloro-3-(3,4-dimethylphenyl)sydnone (26h) [0.23 g, 1.01 mmol] stirred in acetic acid
(2 mL) and acetic anhydride (287 µL, 3.04 mmol) was refluxed at 80°C for 4 hours and then
quenched in DI H2O (~30 mL). The quenched mixture was warmed to 50°C for ~10 minutes
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while stirring. The precipitate became semi-miscible when warmed and precipitated upon
cooling in an ice bath, affording a yellow-orange precipitate. The precipitate was collected via
vacuum filtration and the solid was rinsed with cold DI H2O (~10 mL) to yield 27h as a tan solid
(0.097 g, 47%), m.p. 64-65°C, 1H NMR: 2.17 (3H, s), 2.32 (3H, s), 2.34 (3H, s), 7.17 (1H, s),
7.20 (1H, d), 7.30 (1H, d) δ; 13C NMR: 12.31, 14.42, 20.32, 124.30, 126.20, 130.86, 133.71,
133.85, 138.63, 152.75, 153.98 ppm.
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Appendix
IR Spectra

IR-1. FT-IR of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

IR-2. FT-IR of 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
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IR-3. FT-IR of 5-(thiocyanomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

IR-4. FT-IR of 5-(chloromethyl)-3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one
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GC/MS Spectra

GC/MS-1. GC chromatogram and mass spectrum of crude 5-(bromomethyl)-3-phenyl-1,3,4oxadiazol-2(3H)-one (Rt = 4.649)
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GC/MS-2. Mass spectrum of peak (Rt = 4.100) from crude sample of 5-(bromomethyl)-3phenyl-1,3,4-oxadiazol-2(3H)-one

GC/MS-3. Mass spectrum of peak (Rt = 5.318) from crude sample of 5-(bromomethyl)-3phenyl-1,3,4-oxadiazol-2(3H)-one
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GC/MS-4. GC chromatogram and mass spectrum of 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol2(3H)-one (Rt = 4.134)
80

GC/MS-5. GC chromatogram and mass spectrum of 5-(trichloromethyl)-3-phenyl-1,3,4oxadiazol-2(3H)-one (Rt = 4.689)
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GC/MS-6. GC chromatogram and mass spectrum of 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol2(3H)-one (Rt = 4.575)
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1H

NMR

1H

NMR-1. 1H NMR of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

1H

NMR-2. 1H NMR of 5-(bromomethyl)-3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one
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1H

NMR-3. 1H NMR of 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

1H

NMR-4. 1H NMR of 5-(trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
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1H

NMR-5. 1H NMR of 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
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1H

NMR-6. 1H NMR of 5-(thiocyanomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

1H

NMR-7. 1H NMR of 4-chloro-3-(4-chlorophenyl)sydnone
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1H

NMR-8. 1H NMR of 4-chloro-3-(4-bromophenyl)sydnone

1H

NMR-9. 1H NMR of 4-chloro-3-(3,4-dimethylphenyl)sydnone
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1H

NMR-10. 1H NMR of 4-chloro-3-(4-methoxyphenyl)sydnone

1H

NMR-11. 1H NMR of 4-chloro-3-(4-methylphenyl)sydnone

1H

NMR-12. 1H NMR of 5-methyl-3-(4-bromophenyl)-1,3,4-oxadiazol-2(3H)-one
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1H

NMR-13. 1H NMR of 5-methyl-3-(4-chlorophenyl)-1,3,4-oxadiazol-2(3H)-one

1H

NMR-14. 1H NMR of 5-methyl-3-(4-methylphenyl)-1,3,4-oxadiazol-2(3H)-one
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1H

NMR-15. 1H NMR of 5-methyl-3-(4-methoxyphenyl)-1,3,4-oxadiazol-2(3H)-one

1H

NMR-16. 1H NMR of 5-methyl-3-(4-acetylphenyl)-1,3,4-oxadiazol-2(3H)-one
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13C

NMR

13C

NMR-1. 13C NMR of 5-(bromomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

13C

NMR-2. 13C NMR of 5-(bromomethyl)-3(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one
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13C

NMR-3. 13C NMR of 5-(chloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

13C

NMR-4. 13C NMR of 5-(chloromethyl)-3-(2,4-dinitrophenyl)-1,3,4-oxadiazol-2(3H)-one
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13C

NMR-5. 13C NMR of 5-(trichloromethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

13C

NMR-6. 13C NMR of 5-(azidomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one
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13C

NMR-7. 13C NMR of 5-(thiocyanomethyl)-3-phenyl-1,3,4-oxadiazol-2(3H)-one

13C

NMR-8. 13C NMR of 5-methyl-3-(4-chlorophenyl)-1,3,4-oxadiazol-2(3H)-one
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13C

NMR-9. 13C NMR of 5-methyl-3-(4-bromophenyl)-1,3,4-oxadiazol-2(3H)-one

13C

NMR-10. 13C NMR of 5-methyl-3-(4-methylphenyl)-1,3,4-oxadiazol-2(3H)-one
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13C

NMR-11. 13C NMR of 5-methyl-3-(4-methoxyphenyl)-1,3,4-oxadiazol-2(3H)-one

13C

NMR-12. 13C NMR of 5-methyl-3-(3-methoxyphenyl)-1,3,4-oxadiazol-2(3H)-one
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13C

NMR-13. 13C NMR of 5-methyl-3-(4-acetylphenyl)-1,3,4-oxadiazol-2(3H)-one
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